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Carcinogenicity of Saccharin
by Melvin Dwaine Reuber*
Saccharin is carcinogenic for the urinary bladder in rats and mice, and most likely is carcinogenic
in human beings. The neoplasms of the urinary bladder are malignant and invade and metastasize.
Male rats are more susceptible to urinary bladder carcinogenesis than female rats. Rats
exposed as fetuses develop neoplasms more readily than rats exposed as weanlings. The lesions in the
urinary bladder go through the stages of hyperplasia, hyperplastic nodules, and later carcinomas. The
male of the human species ingesting saccharin, as for rats, is more susceptible to carcinogenesis of the
urinary bladder than the female. Neoplasms of the urinary bladder in rats were not caused by stones,
parasites, sodium, or impurities. Carcinomas developed at the same time or prior to the development of
stones in rats with both. There is a cocarcinogenic effect between saccharin and methyinitrosurea for the
urinary bladder.
Even though carcinomas ofthe urinary bladder are present in rats given the higher doses ofsaccharin,
one was observed in a female rat given 0.5%. Chronic renal disease develops in rats ingesting saccharin.
The disease is more advanced at the lower doses than at the higher doses, suggesting that saccharin at the
lower doses does not reach the urinary bladder. Early neoplasms are seen in the renal pelvis of rats given
the higher doses of saccharin. The risk ratios for urinary bladder carcinomas in human beings increase
with both frequency and duration of saccharin usage.
Benign and malignant neoplasms at all sites are significantly increased in mice and rats ingesting the
higher doses of saccharin. These neoplasms are present in the reproductive and hematopoietic systems,
and to a lesser extent in the lungs, vascular system and squamous epithelium. Neoplasnms in some organs
develop with the lower doses ofsaccharin. Lymphosarcomas ofthe lung are significantly increased in rats
given 0.01% saccharin. Chronic renal disease in rats given saccharin interferes with the health and life
span and consequently with the development ofneoplasms. Saccharin initiates neoplasms ofthe skin when
its application is followed by croton oil. Epidemiological studies have not been done for neoplasms other
than the urinary bladder in human beings.
Introduction
This report reviews the published and unpub-
lished carcinogenicity studies on saccharin, a non-
nutritive sweetner. They are from files at the Na-
tional Academy of Science (I), Food and Drug Ad-
ministration (2), and the National Cancer Institute
(3). The results ofonly 5 of 11 studies in which rats
ingested saccharin and 2 of4 studies in which mice
ingested saccharin have been published, and it is
likely that most will never be published (Table 1).
This review is my own analysis of the data which
are, in most cases, raw data. Whenever possible,
the number of animals is corrected for survival
time.
* Chemical Carcinogenesis Program, NCI Frederick Cancer
Research Center, Frederick, Maryland 21701.
The results are reported as tumors: in the urinary
system, in the reproductive system, in the
hematopoietic system, involving squamous
epithelium, in the lungs and vascular system, and in
all organs. In addition, studies in animals are com-
pared to human studies.
The statistical analyses are one-sided p (proba-
bility) values (4).
0 0
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August 1978 173Table 1. Studies reviewed.
Rat studies (oral)
Lessel study (5-7)
FDA study (1948-1949) (8)
Schmahl study (9-10)
Litton Bionetics study (12)
Bio-Research Consultants study (14)
Munroe et al. study (15)
Hicks et al. study (1973, 1975) (17, 18)
WARF Institute study (/9)
FDA study (1973) (20-22)
Canadian Health Protection Branch study (1977) (23, 24)
National Institute of Hygienic Sciences study (39)
Mouse studies (oral)
Bio-Research Consultants study (14)
Kroes et al. study (30)
National Institutes of Hygienic Sciences study (32)
Roe et al. study (36)
Other studies
Althoff et al. study (38)
McChesney et al. study (39)
Allen et al. study (26)
Bryan et al. study (27)
Tumors Involving the Urinary
Bladder
Rat Studies
Lessel Study. Boots-Wistar male and female rats,
20 per group, ingested 0%o, 0.005%, or 5% saccharin
in the diet (5, 6). Rats were killed after 2 yr. A
positive control group was given subcutaneous try-
pan blue. Special attention was given to examina-
tion of the urinary bladder of a few rats, i.e., those
that were grossly abnormal. Therefore, histological
examination ofthe urinary bladder was inadequate.
"'Abnormalities" of the urinary bladder occurred
more often in the urinary bladder of males than in
females, and were more frequent in rats ingesting
5% saccharin than in rats ingesting other doses
(Table 2).
Histologic examination of the urinary bladder in
one male rat ingesting 5% saccharih disclosed slight
hyperplasia ofthe mucosa. One female rat ingesting
5% saccharin for 24 months had papillomatous
Table 2. Number ofmale and female rats ingesting saccharin with
"gross abnormalities" of the urinary bladder.
No. of rats
Dose, % Male Female
O 2/20(10%o) 0/20(0o)
0.005 1/20(5%) 0/20(0%o)
0.05 4120(20Wo) 0/20(0o)
0.5 1120(10%) 0/20(0o)
5 5/19(26%o) 3/18(17%)
a Rats surviving 6 months or longer.
hyperplasia with squamous metaplasia and another
rat a papilloma of the bladder.
Four of five male rats with gross abnormalities
had stones in the urinary bladder. Two of the blad-
ders with stones were studied histologically, but
apparently the bladder with a lesion and without
stones was not studied. One female rat had a papil-
loma with a stone and another papillomatous hy-
perplasia without a stone. None ofthe rats given the
lower doses or the controls had bladder stones.
The author states that there have been no lesions,
tumors, stones, or nematodes ofthe urinary bladder
occurring in untreated Boots-Wistar rats (7).
In this study, early tumors ofthe urinary bladder
occurred in at least two female rats ingesting 5%
saccharin. One tumor was associated with a bladder
stone, but the other was not. The causal relation-
ship ofthe tumors to the stones, or of the stones to
the tumors, cannot be determined from this study.
Animals need to be killed at frequent time intervals
in order to study this problem.
FDA Study (1948-1949). E. L. Long and R. T.
Haberman, pathologists at the FDA, with the as-
sistance of Dr. Harold L. Stewart, reviewed all the
available data and microscopic slides from the
long-term rat feeding study on saccharin done at the
FDA (8). Groups of 3-week-old Osborne-Mendel
rats, 20 per group evenly divided by sex, were given
0o, 0.01%, 0.1%, 0.5%, 1%, or 5% saccharin in the
diet for 2 yr. There was a control group of 53 rats.
(It should be noted that there was only a slight de-
gree of acute and chronic pneumonia in the un-
treated and treated rats of all groups.)
Although all urinary bladders were opened and
described as being grossly normal, only one was
sectioned and, on histological examination, ap-
peared normal. Additional sections, at different
levels, were cut from the original blocks ofthe kid-
neys with suspicious lesions.
Rats that had been given saccharin had papillary
excrescences, calcification in the renal pelvis, and
venous thrombosis, and the lesions were clearly
dose-related (Table 3). The papillary lesions were
present in 17% of rats at the 1% dose level, and in
76% of the rats at the 5% dose level of saccharin.
There were calcifications in 76% and venous
thrombosis in 24% of rats given 5% saccharin.
There was also chronic interstitial nephritis that was
much more severe in rats given saccharin, but was
not related to the papillary lesions of the renal pel-
vis. No sex differences were evident.
The lesion "'was characterized by small papillary
projections or excrescences from the renal papilla,
calyx, or papillo-calyceal junction.... They ap-
peared to be the result of a combination of the fol-
lowing changes: very slight to marked degrees of
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ingesting saccharin.
No. of rats
Epithelial Venous
Dose, % Hyperplasia Calcification thrombosis
0 1/33(2%) 1/53(2%) 0/53(0%)
0.01 0/13(0%b) 0/13(0%) 0/3 (0O)
0.1 0/15(0%) 0/15(0SO) 0/15(0%o)
0.5 1/15(7%) 2/15(13%) 0/15(0%o)
1 3/1t8(17%) 1/18(6%) Q/18(0%o)
5 13/17(76%)a 13/17(76%) 4/17(24%o)
(p = 0.000000084)b (p = 0.000000001)b (p = 0.000742)b
a The additional sections increased the number of lesions in
the rats given 5% saccharin from 5 to 13.
b Statistical analyses are one-sided p (probability) values (4).
stratification of the epithelium and the single layer
ofcuboidal cells that normally cover the papilla and
calyx ofthe rat to several layers ofcells (i.e., to the
transitional type which in the rat is normal in the
renal pelvis but not in the calyx or papilla) in all
affected animals.'"
They concluded that ""this lesion of the renal
papilla was undoubtedly the result of the adminis-
tration of saccharin." They went on to state "the
question naturally arises as to the relation of these
renal lesions to the papillary carcinomas and papil-
lomas ofthe bladder produced by the recent Abbott
study employing a mixture of cyclamates and sac-
charin, since the papilla and calyx are adjacent to
the pelvis and both bladder and renal pelvis are
lined by similar epithelium (transitional) and would
consequently be expected to give rise to similar
tumors."
With regard to the failure to section the urinary
bladders histologically: "'In view of the Abbott
cyclamate-saccharin study in which, although some
of the bladder tumors found were visible grossly,
others were identified only after histologic exami-
nation. . . . While there was epithelial hyperplasia
in the FDA rats, in no case was there a true tumor,
although in one case (10078) the proliferation was
striking enough to be called papillomatoid or pre-
neoplastic," and implied that this study could not
be considered a negative one for tumors of the uri-
nary bladder.
The authors said with reference to the renal pelvis
lesion. ""It is also a lesion we have never seen be-
fore." The lesion occasionally occurs in rats in-
gesting a renal and hepatic carcinogen, N-4-
(4'-fluorobiphenyl) acetamide, in the diet, as well as
in the kidney of rats given several chlorinated hy-
drocarbon pesticides (9). In some cases, the lesions
were advanced enough to be reported at least as
papillomas or preneoplastic lesions. The epithelial
hyperplasia in the renal pelvis is identical to that
considered as preneoplastic or a precursor to trans-
itional carcinomas of the urinary bladder, and
should therefore be considered as a precursor of
transitional cell carcinoma in the renal pelvis. In
most instances, however, the lesion was discovered
on random sectioning of the kidney, and not after a
careful systematic examination.
The presence of a dose-related response to the
development of epithelial hyperplasia of the renal
pelvis suggests that the earliest effects of saccharin
are on the epithelium ofthe renal pelvis. There was
also treatment-related chronic renal disease in rats.
It may well be that higher dose levels of saccharin
are necessary in order for sufficient levels to reach
the urinary bladder and to induce lesions there.
In summary, saccharin given in the diet to both
male and female Osborne-Mendel rats induces
transitional cell hyperplasia of the renal pelvises
and calyces, referred to as papillary lesions. The
lesion is dose related, with the most severe lesions
occurring at the 5% dose level. Other chemicals
cause a similar more advanced preneoplastic
hyperplasia or papillomas in the renal pelvis.
The following conclusions were drawn. Since the
urinary bladders were not sectioned and studied
histologically, this study cannot be considered as
negative for tumorigenicity of the urinary bladder.
Because of the similarity of the epithelium of the
renal pelvis and the urinary bladder, there exists the
potential for the induction of similar lesions in the
urinary bladder. The epithelial hyperplasia in the
renal pelvis is identical to that in the urinary bladder
that is considered to be a precursor to carcinomas of
the urinary bladder, and should therefore be con-
sidered as a precursor to carcinoma of the renal
pelvis. It may be necessary to administer higher
doses of saccharin in order for sufficient levels to
reach the urinary bladder after the earlier contact
with the kidney and renal pelvis.
The results of this study suggest that more com-
plete examinations ofthe urinary system are neces-
sary in rats given saccharin. The epithelium of the
renal pelvis and ureters, as well as the interstium of
the kidneys, should also be studied in addition to
the urinary bladder.
Schmahl Study. Schmiihl studied the effect of
saccharin, with emphasis on the urinary bladder, in
Sprague-Dawley rats because they developed car-
cinoma of the urinary bladder when given butyl-
butanol nitrosamine (10, 11). Fifty-two male and 52
female rats, 70-90 days old, were given 0%o, 0.2%,
or 0.5% sodium saccharin in a pellet diet for their
lifetime. They also gave rats the much higher doses
of 2% or 5% cyclamate.
The urinary bladder was examined histologically
in all rats; however, further histologic examinations
were done "'when organs seemed pathologically
August 1978 175changed." All rats started in the study were in-
cluded as at risk in the study. The results were not
separated by sex.
There were no carcinomas of the urinary bladder
in rats ingesting saccharin. One rat given 2% cycla-
mate for 27 months developed a transitional cell
carcinoma ofthe urinary bladder, which was attrib-
uted to bladder stones. The 16% of rats with para-
sites (strongyloides) observed on histologic sections
of the urinary bladder, did not have lesions or
tumors of the bladder.
It was concluded that at the relatively low dose
levels of 0.2% or 0.5%, carcinomas were not ob-
served in the urinary bladders of rats.
The results obtained were under the conditions of
this experiment: incomplete histology, failure to
separate the results by sex, including all rats at risk
for the development of tumors, and using a strain
with a high incidence of "'spontaneous" tumors.
Furthermore, "most of the animals died from typi-
cal infections of the respiratory tract."
Rats with urinary bladder parasites were de-
scribed as not being more susceptible to the induc-
tion of bladder tumors.
Emphasis appears to be placed on the develop-
ment of tumors, without describing other changes.
Litton Bionetics Study. Litton Bionetics
studied the chronic effects of sodium saccharin in
Charles River CD strain male and female rats (12).
Rats ingested 0%o, 1%, or 5% sodium saccharin in
the diet for up to 2 yr. There were two duplicate
studies with the same experimental design.
One of 26 female rats ingesting 5% sodium sac-
charin had a papilloma ofthe urinary bladder in the
second study. One of26 male rats ingesting the high
dose developed hyperplasia of the urinary bladder
in the first study. Lesions of the urinary bladder
were not found in groups of 20 male and 20 female
controls in either study.
Chronic glomerulonephritis was found in 17 of26
(65%) males and 1 of 26 (4%) females ingesting 1%
saccharin in the diet. No mention was made of le-
sions of the renal pelvis.*
The data from these studies was analyzed at the
NCI and the following conclusion was drawn (13).
"A papilloma ofthe urinary bladder was found in a
single female ofthe high dose saccharin group in the
second replicate. This was the only bladder tumor
found in the study. In the first replicate, hyperplasia
of the urinary bladder was found in the high dose
male group. Although these findings are not statisti-
cally significant, they do not, on the other hand,
show saccharin to be safe. Because of the small
* In view ofthe renal pelvic lesions described in the kidney by
Long and Haberman, it would be desirable to reevaluate the
kidney sections in this study also.
numbers of animals tested, this experimental result
is consistent with very high possible urinary bladder
tumor effect by saccharin in rats."
The conclusion that can be made from this study
is that it is likely that saccharin is tumorigenic for
the urinary bladder. Saccharin at the 1% dose level
also induced a high incidence of chronic renal dis-
ease in male rats.
Bio-Research Consultants. Bio-Research Con-
sultants carried out two separate studies with the
same experimental design on the chronic effects of
sodium saccharin in rats (14). The saccharin from
two sources (Merck or Monsanto) was stated as not
containing impurities. Charles River Sprague-
Dawley male rats, 25 in each group, ingested 0Wo,
1%, or 5% sodium saccharin in the diet for 104
weeks or longer. Female rats were not included in
this study.
Millipore filter preparations were made of urine
ofmale rats at the time ofautopsy, or, ifthe bladder
was empty, of saline washings of the bladder. The
filters were stained and studied for parasites and
ova. The bladder was then inflated with formal-
dehyde, the uretha ligated, and the bladder fixed.
Histological sections of bladders and kidneys were
reviewed by G. W. Friedell, St. Vincent Hospital,
Worcester, Massachusetts. Urinary bladders were
notexamined ifrats were too autolyzed forautopsy.
There was one carcinoma of the urinary bladder
in a rat on the high dose ofsaccharin and one papil-
loma in a rat on the low dose in one group (Table 4).
In the other group, one carcinoma was present in a
rat on the low dose and one papilloma was found in
a rat on the high dose. One control rat also had a
carcinoma of the urinary bladder.
Ova consistent with Trichosomoides crassicauda
were present in urine ofapproximately one-third of
the rats. There was no correlation between the
parasite and tumors of the bladder.
The transitional cell epithelium of the renal pelvis
frequently had atypical hyperplasia, often as-
sociated with gross calcification in rats of all
groups. However, this lesion was seen most often in
male rats ingesting the high dose of sodium saccha-
rin. One rat ingesting the low dose of saccharin had
an 'adenoma" of the kidney.
The incidence of tumors of the urinary bladder
Table 4. Tumors of the urinary bladder in male rats ingesting
sodium saccharin in both studies.
No. rats
Dose, % Group I Group 2 Total
0 Matched 1/16(6%)
Pooled 5/111(5%)
1 1/13(8%) 1/15(7%) 2/28(7%)
5 1/12(8%) 1/14(7%) 2/26(7%)
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ever, rats with papillomas or carcinomas ofthe uri-
nary bladder did not have bladder stones and there
was no relationship to parasites ofthe urinary blad-
der. The saccharin was stated as not containing im-
purities.
Tumors of the renal pelvis (atypical hyperplasia)
often seen in male rats ingesting the high dose of
saccharin have been described in other previous
chronic feeding studies in rats (8).
Study of Munroe et al. Munroe et al.
studied the carcinogenicity of commercial saccharin
in male and female Charles River weanling rats
weighing 50-60 g (15). Groups of 60 male and 60
female rats were given sodium saccharin at levels of
0, 90, 270, 810, or2430 mg/kg-day in a synthetic diet
for 26 months. Constant levels were given by ad-
justing amounts at weekly intervals. The urinary
bladder, as well as "other grossly abnormal or-
gans," were examined histologically. At the start,
10 rats per group, and at 23 months all surviving
rats, were examined for the bladder parasite T.
crassicauda by collecting and examining samples of
urine for parasite eggs.
Four transitional cell papillomas of the urinary
bladder were observed in the treated rats and none
in the control rats (Table 5). The only otherlesion of
the epithelium was malakoplakia in one male re-
ceiving the highest dose level of sodium saccharin.
Two of the papillomas were described as 2 cm in
size and entirely filled the bladder cavity; the other
two did not exceed 3 mm. Three rats with urinary
bladder calculi did not have tumors of that organ.
Ova of T. crassicauda were not found in the urine.
Histological sections of the bladder tumors were
reviewed by a NAS Subcommittee Panel on Pathol-
ogy in 1973. There was unanimous agreement that
two of the tumors diagnosed as papillomas were
transitional cell carcinomas, one with invasion (16).
There is an illustration of a "calculus" in the
Table 5. Male and female rats ingesting saccharin with epithelial
tumors of the urinary bladder.a,b
No. rats
Dose, mg/kg Males Females Total
0 0/57c 0/56 0/113
90 1/51 1/56 2/107
270 0/59 0/52 0/106
810 2/52 0/56 2/108
2430 0/54 0/54 0/108
a Total number is equal to the number of rats examined his-
tologically.
b The effective number of rats, or rats that survived long
enough to develop tumors, is not given. Only about 40 rats per
group were alive at 18 months.
c One rat in this group had an "angiosarcoma" of the submu-
cosa which was of vascular origin.
medulla of the kidney of a saccharin-treated rat;
however, data as to numbers of rats with such his-
tologic lesions is unreliable if only selected kidneys
are sectioned and studied histologically (8).
It was concluded that small numbers of sodium
saccharin-treated rats, under the conditions of this
study, developed transitional cell papillomas and
carcinomas ofthe urinary bladder. The incidence is
not certain because the number ofeffective rats was
not given.
The rats with tumors of the urinary bladder were
free of the bladder parasite T. crassi(auda and did
not have bladder stones. Parasites and bladder
stones, therefore, were not the cause ofthe bladder
tumors.
It cannot be concluded from this study that sac-
charin is not carcinogenic for the urinary bladder.
There were, in fact, two transitional cell papillomas
and two transitional cell carcinomas (one invasive)
of the urinary bladder in the treated rats suggesting
that saccharin is most likely carcinogenic for the
urinary bladder.
Study ofHicks et al. (1973). A rat model for
studying the induction of urinary bladder cancer
using intravesicular instillation of methylnitro-
sourea (MNU) was developed by Hicks et al. (17).
A single dose of 2.0 mg MNU into the bladder of a
150 g Wistar rat acts as an initiator but does not
produce carcinoma unless its action is promoted by
further doses. In the first few weeks there is a
transient hyperplastic response of the bladder epi-
thelium; however, the epithelium is normal in ap-
pearance after more than 12 weeks.
The effect ofdietary saccharin on the response of
the urinary bladder to MNU was studied in female
Wistar rats, 50 per group, ingesting 41B pelleted
diet. In the first group, each rat had a single dose of
2 mg MNU instilled through urethral catheter into
the bladder at the start of the study. In the second
group, saccharin was added to the drinking water;
the rats were weighed and the saccharin content of
the water adjusted to maintain an intake of2 g/kg of
body weight daily throughout the study. Rats in the
third group received saccharin and each rat had a
single dose of MNU 6 weeks after the start of the
saccharin regime. Control rats received no treat-
ment. Twelve rats in each group were killed be-
tween 3 and 56 weeks. The urinary bladders were
distended with fixative at necropsy and examined
grossly and histologically.
Nine of 12 rats (75%) receiving both MNU and
saccharin developed marked changes ofthe urinary
bladder epithelium (Table 6). Three (25%) has inva-
sive transitional and squamous cell carcinoma. In
two others there were hyperplastic nodules and
papillomas. Some animals also had calculi in the
August 1978 177Table 6. Lesions ofthe urinary bladder in rats receiving saccharin
and methylnitrosourea (MNU).
No. of Time killed, No. of rats
Lesion rats weeks with calculia
None 1 20 0
Mild hyperplasia 2 3, 10 I
Severe hyperplasia 4 12, 13, 16, 30 1
Hyperplastic nodules 2 8, 24 2
and papillomas
Carcinomas with invasion 3 21, 50, 50 3
a Of rats given MNU, 20%W develop only calculi without
tumors.
bladder. Two of 12 rats given saccharin only had
mild hyperplasia after 36 weeks, and none had cal-
culi.
The results indicate that rats given both MNU
and saccharin develop varying degrees of
hyperplasia, followed by hyperplastic nodules and
carcinomas with invasion. Severe hyperplastic le-
sions were present after 12 weeks, nodules after 24
weeks, and carcinomas after 50 weeks. Rats given
MNU only had transient mild hyperplasia. There-
fore, it is clear that saccharin was responsible for
the progression of that mild hyperplasia to more
advanced tumors and carcinomas. Rats given MNU
plus cyclophosphamide developed hyperplasia but
not carcinomas ofthe urinary bladder. Hyperplasia
that is not severe and that does not develop early
will not become nodules and carcinomas.
Urinary bladder calculi were present in 7 of 12
rats given saccharin and MNU; whereas 20% ofrats
given MNU only develop calculi without tumors.
Calculi developed after tumors of the urinary blad-
der and were not responsible for the tumors in rats
given both chemicals.
Remaining animals were to have been killed dur-
ing the second year of the study; however, the re-
sults have not been obtained.
The authors concluded: "'Our experiments show
that saccharin is cocarcinogenic in conjunction with
a single dose ofMNU, and indicate that a promoting
action of saccharin with cyclamate and/or other
bladder carcinogens is an obvious possibility."
They also pointed out that cyclamate and saccharin
was usually consumed together by man in a 10:1
ratio mixture.
Study ofHicks et al. (1975). Wistar male and
female rats were given 2 or 4 g/kg of body weight
daily ofsodium saccharin for 2 yr(18). Other groups
offemale rats were given a single dose of 1.5 mg of
MNU into the urinary bladder. Other rats received
cyclamate or cyclophosphamide.
A small number of rats given 4 g/kg sodium sac-
charin alone developed tumors of the urinary blad-
der (3 of 138) after 95 weeks. Twenty-three of 49
(47%) and 27 of 47 (57%) MNU-treated rats receiv-,
ing saccharin had tumors of the urinary bladder as
early as 10 weeks (Table 7). The tumors in MNU-
treated rats were more malignant and invasive than
those in rats given saccharin alone. Urinary bladder
tumors were not seen in rats given MNU alone.
Bladder tumors had not been observed "spontane-
ously" in 600 rats in over a 10-yr period.
Some of the rats with tumors of the urinary blad-
der also had stones. Thirteen rats given a single
dose of MNU had stones, but none developed
tumors. Five rats receiving MNU plus saccharin
and four given MNU plus cyclamate had bladder
tumors without stones. The authors concluded: "In
these experiments a calculus alone was thus not
able to promote tumor formation in an MNU-
primed bladder in the absence of some further
specific carcinogenic stimulus. That further
stimulus was clearly given by the additional doses
of MNU or by including saccharin or cyclamate in
the diet.'"
'The calculus is thus not an obligatory factor in
the syncarcinogenic effect of these sweeteners. For
all this work specific pathogen-free rats were used
and there were no infections with the worm,
Trichosolnoidcs (rassi(caId(.
They also discussed the use of an animal model,
which depends upon the synergy ofcompounds, for
the testing of chemicals for carcinogenicity.
"Man, however, is exposed to a complex envi-
ronment, in which he may simultaneously en-
counter potentially carcinogenic chemicals in the
food he eats, in the air he breathes, in the tobacco
smoke he inhales, and in the factory where he
works. Any individual suspect compound may be
present in such low amounts that if tested singly at
'relevant' concentrations its effect may be negligi-
ble or even undetectable, even though in combina-
tion with other environmental factors its effect
could well be significant. There is thus some justifi-
cation for looking for compounds which are syner-
gistic with other known bladder carcinogens."
In summary, this study demonstrated a cocar-
cinogenic effect between methylnitrosourea and
saccharin. Stones and parasites were not responsi-
ble for this carcinogenicity.
Table 7. Tumors of the urinary bladder in rats given
methylnitrosourea and/or saccharin.
Dose, No. of rats with tumors of urinary bladder
g/kg-day Saccharin MNU + saccharin
2 0/1 15(0%7)a 23/49(47%)
(p = 0.000000000000008709)
4 3/138(2%)a 27/47(57%)
(p = 0.000000000000000132)
a Male and female rats were combined.
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(WARF) Institute Study. The WARF Institute
(International Sugar Foundation) study used
Sprague-Dawley (F1) male and female weanling rats
(19). (F1 were the litters offemale rats given saccha-
rin. Treated rats were exposed to saccharin from
inception.) Male and female rats, 20 per group, in-
gested 0%o, 0.05%, 0.5%, or 5% sodium saccharin in
Purina laboratory chow for 100 weeks. Most tissues
were sectioned histologically, including the urinary
bladder.
Male rats, particularly at the 5% dose level of
saccharin, developed a high incidence of bladder
tumors (50t%), and most of the tumors were transi-
tional cell carcinomas; whereas the untreated males
did not have a single tumor of the urinary bladder
(p = 0.00123) (Table 8). One female rat given 0.05%
saccharin had an undifferentiated malignancy in the
urinary bladder (Table 9). Stones were not present
in the urinary bladder.
Histological sections of some of the bladder
tumors were reviewed by a Subcommittee Panel on
Pathology in 1973. There was unanimous agreement
that the tumors were transitional cell carcinomas
and that two of the carcinomas were invasive (16).
Additional data, including lesions of the renal
pelvis and kidneys, would be helpful in interpreting
the relationship of dose to lesions of the urinary
bladder. Information concerning parasites was not
given.
In conclusion, saccharin is carcinogenic for the
urinary bladder of rats. Some of the carcinomas
were invasive. Stones were not related to the de-
velopment of urinary bladder tumors. Male rats
were more susceptible to the development of car-
cinomas of the urinary bladder than were female
rats.
FDA Study (1973). Male and female Charles
River Sprague-Dawley rats, F, generation, 48 per
group, ingested 0%, 0.01%, 0.1%, 1%, 5%, and
7.5% sodium saccharin in the diet for 28 months
(20). Control rats were given a diet containing
sodium carbonate at the same level as that ingested
by the rats given 5% sodium saccharin. Some rats
were killed after 14 and 18 months. Rats from the Fo
generation were killed after 4, 6, and 12 months
(21). Special attention was given to examining the
urinary bladder.
The incidence of carcinomas and papillomas of
the urinary bladder were significantly increased in
male rats ingesting 7.5% saccharin for 24 months
(p = 0.01755) (Table 10). The incidence of car-
cinomas and polypoid hyperplasia of the urinary
bladder was increased in female rats given the same
dose level (Table 11). Males were more susceptible
to carcinogenesis ofthe urinary bladder than female
rats.
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Table 8. Lesions of the urinary bladder in male rats ingesting
saccharin.
No. of lesions
Hyperplasia ofthe Carcinoma of the Total
Dose, % urinary bladder urinary bladder tumors
0 0/16(0%) 0/16(0%) 0/16(%)
0.05 0/16(0%) 0/16(0%o) 0/16(0%)
0.5 1/15(7%)a 0/15(0%) 1/15(7%)
5 I/16(6%)b 7/16(44%) 8/16(50%o)
(p = 0.00340) (p = 0.00123)
(p = 0.0000185)' (p = 0.000026)d
a Considered as 'precancerous."
b Described as "papillary projections."
" Tested against 0/48.
" Tested against 1/47.
Table 9. Lesions of the urinary bladder in female rats ingesting
saccharin.
Carcinoma of the
Dose, % urinary bladder
0 0/17(Wo)
0.05 1/17(6%)a
0.5 O/15(0o)
5 0/20(Wo)
a Undifferentiated malignancy.
Table 10. Lesions of the urinary bladder in male rats ingesting
sodium saccharin in the diet for 24-28 months.
No. of lesions
Dose Papillomasofthe Carcinomas ofthe Total tumorsof
% urinary bladder urinary bladder the urinary bladder
0 0/25(0%) 1/25(4%) 1/25(4%)
5 0/21(0%) 1/21(5%) 1/21(5%)
7.5 1/23(4%) 6/23(26%)0.038 7/23(30o)0.01755
(p = 0.013S903y (p = 0.00489)a
"1 Tested against 2/46.
Table 11. Lesions of the urinary bladder in female rats ingesting
sodium saccharin in the diet for 24 months.
No. of lesions
Polypoid hyperplasia Total tumors
ofthe Carcinomasofthe ofthe
Dose, % urinary bladder urinary bladder urinary bladder
0 0/24(%o) 0124(0%o) 0/24(%o)
5 0128(0o) 0/28(0%o) 0/28(0%o)
7.5 2/31(6%o) 2/31(6%) 4/31(13%)
(p = 0.09226)
(p = 0.01712)p
"Tested against 0/52.
The Subcommittee of Pathology reviewed
selected slides from this study and confirmed the
presence of transitional cell carcinomas, one with
invasion of the urinary bladder (16).
Lesions ofthe urinary bladder were classified ac-
179cording to the severity of the hyperplasia, i.e.,
minimal isolated focus of hyperplasia of the mu-
cosal epithelium, slight hyperplasia of the mucosal
epithelium, moderate hyperplasia of the mucosal
epithelium, and marked hyperplasia ofthe mucosal
epithelium. The tumors were classified as polypoid
hyperplasia of the mucosal epithelium, transitional
cell papillomas, early transitional cell carcinomas,
and transitional cell carcinomas (usually papillary).
The severity of the hyperplasia and the develop-
ment of tumors of the urinary bladder were related
to the duration ofingestion of sodium saccharin, as
well as to the dose level ingested. At the end of 4
months animals at the lower doses had minimal
isolated foci of hyperplasia, except for two rats
given 7.5% saccharin that had slight hyperplasia.
Rats developed slight and moderate hyperplasia by
6 months and moderate hyperplasia by 12 and 18
months.
Polypoid hyperplasia, papillomas, and transi-
tional cell carcinomas were present in rats at 24 to
28 months given the 7.5% dose level. One male rat
given 5% saccharin had an early transitional cell
carcinoma. Rats with polypoid hyperplasia, papil-
lomas, or carcinomas sometimes also had moderate
or marked hyperplasia. In addition, rats without
tumors at the lower dose levels had hyperplasia of
the urinary bladder at 24 to 28 months.
Hyperplasia ofthe urinary bladder was increased
in male rats (32%) and in female rats (15%) given
7.5% sodium saccharin (Tables 12 and 13). Control
male rats with bladder lesions had slight or moder-
ate hyperplasia and female rats had slight
hyperplasia at 24 to 28 months. The increase in
hyperplasia is significant in the male andfemale rats
ingesting 7.5% saccharin (p = 0.004046).
There were other changes observed in the urinary
bladder; however, these lesions were not related to
the development of hyperplasia or tumors. These
were mucus, proteinaceous casts, and cystitis. A
few rats with mucus and proteinaceous casts also
had hyperplasia of the urinary bladder; however,
most did not. Five rats with slight or moderate
hyperplasia also had cystitis.
Perhaps of greater interest was the finding of
bladder stones and the absence of parasites (Table
14). Bladder stones were found in 67% of treated
male rats at the end of 12 months. Not one rat with
bladder stones developed either hyperplasia or
tumors ofthe urinary bladder. Bladder stones were
not observed in female rats. Parasites ofthe urinary
bladder were not observed.
Chronic interstitial nephritis was more advanced
at the lower dose levels and less advanced at the
higher dose levels of sodium saccharin; whereas
"polyposis" of the calyceal of the kidney was the
Table 12. Number ofmale rats ingesting saccharin at various dose
levels with hyperplasia of the urinary bladder.a
No. of rats
months 0 0.01% 0.1% 1% 5% 7.5%
4 0/15 0/16 1/19 1/19 1/7 2/4
6 1/29 1/31 0/35 0/32 3/20 4/18
12 1/12 1/18 0/15 1/15 0/16 4/15
18 0/7 1/6 0/4 0/7 0/7 4/6
24 8/24 3/16 4/27 3/22 3/21 7/23
Total 10/87 6/87 51100 4/95 7/61 21/66
(p = 0.00190)
(12%) (7%) (5%) (4%) (11%) (32%)
a Rats with tumors that also have hyperplasia are included.
Table 13. Number of female rats ingesting saccharin at various
dose levels with hyperplasia of the urinary bladder.a
Duration, No. of rats
months 0 0.01% 0.1% 1% 5% 7.5%
4 0/13 0/13 0/18 1/17 0/8 1/4
6 1/48 0/49 0/48 0/50 1/37 4/35
12 0/7 0/5 0/3 0/4 1/6 0/5
18 0/6 0/4 0/5 0/6 0/7 0/5
24 2/24 0/23 0/24 3/30 3/28 7/31
Total 3/98 0/94 0/98 4/107 5/86 12/80
(3%) (O%o) (O%o) (4%) (6%) (15%)
(p = 0.004046)
a Rats with tumors that also had hyperplasia are included.
Table 14. Number of male and female rats ingesting
sodium saccharin with bladder stones.
No. bladder stones
Duration, Male rats Female rats
months Treated Untreated Treated Untreated
4 0/70 0/15 0/65 0/13
6 6/209 0/48 0/176 0/29
12 12/18 2/7 0/58 0/12
18 1/28 0/6 0/30 0/7
24 0/136 0/24 0/109 0/25
Total 19/461 2/90 0/438 0/86
opposite. Polyposis, which was not described in
detail, occurred more frequently in the rats given
7.5% saccharin than in the controls (p = <0.05)
(22).
Male rats with carcinomas of the urinary bladder
ingesting higherdose levels ofsodium saccharin had
more severe polyposis ofthe calyceal ofthe kidney,
and less advanced chronic nephritis. Hyperplasia of
the urinary bladder developed as early as 4 months,
but polyposis was not seen until 18 months. This
finding suggests that if polyposis is present in male
rats after 18 months, it is associated with lesions of
the urinary bladder.
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and Haberman with the help of Stewart, suggests
that this study of urinary bladder is not complete
without a careful examination of the epithelium of
the renal pelvis, as well as the entire kidney and
ureter (8).
Conclusions that can be drawn from this study
are as follows.
Sodium saccharin is carcinogenic for the urinary
bladder of male and female rats, with male rats
being more susceptible than female rats.
Saccharin given to rats induces hyperplasia, as
well as carcinomas, of the urinary bladder. The de-
velopment of these lesions was related to the time,
as well as to the dose. Hyperplasia was present at 4
months as minimal foci, and increased in severity
from slight to moderate and marked, as observed at
6, 12, and 18 months. Later polypoid hyperplasia,
papillomas, early transitional cell carcinomas, and
large carcinomas developed.
Hyperplasia and tumors of the urinary bladder
were related to the dose at three different dose
levels, and the lesions were present in higher num-
bers in male rats than in female rats. If rats with
hyperplasia of the urinary bladder at 2 years had
survived for a longer period of time, the incidence
of tumors of the urinary bladder would have in-
creased.
Bladder stones were never associated with
tumors of the bladder. Some rats ingesting saccha-
rin developed bladder stones, but not a single rat
with a bladder stone had either hyperplasia or
tumors of the urinary bladder. Parasites of the uri-
nary bladder were not observed.
Lesions of the urinary bladder in rats ingesting
saccharin cannot be related to the presence of uri-
nary bladder stones or parasites as has been claimed
in earlier studies using small numbers of rats. They
are not caused by sodium.
Weinberger Analysis of FDA Study
(1973). Dr. Morris A. Weinberger, Director, Di-
vision of Pathology, FDA, had the following com-
ments and conclusions concerning the histopathol-
ogy report of the FDA Study by Willigan (20, 22).
"Under these test conditions sodium saccharin
induced transitional cell neoplasms of the urinary
bladder in Charles River rats. The incidence of the
neoplasms ofthe 75,000 group in comparison to the
controls was statistically significant (p = < 0.025
using chi-square analysis)."
"'Most of the carcinomas were classified by Dr.
Willigan as transitional cell carcinomas (papillary
and non-papillary). I generally concur in his find-
ings."
"'The histopathology, site of origin (dome of the
bladder), morphologic characteristics, extent of in-
vasiveness, etc. ofthese neoplasms are remarkably
similar to those that I reviewed in the WARF
chronic toxicity study. They also resemble the
cyclamate-induced urinary bladder tumors of the
FDA study. "
"'Predisposing factors, e.g., bladder parasites,
bladder stones, seminal vesicle casts, crystals, or
crystal deposits were not seen to play a role in the
genesis of the bladder neoplasms."
'The degree of malignancy ofthe tumors may be
assessed from (i) morphologic characteristics, (ii)
biologic behaviors. Morphologically, most of the
tumors have been classified as transitional cell car-
cinomas."
Canadian Health Protection Branch Study
(1977). Male and female Charles River Sprague-
Dawley rats of the Fo generation, 50 per group and
30 days of age, ingested 2500 mg/kg-day sodium
saccharin in a standard laboratory diet for 142
weeks (23, 24). Saccharin was produced by the
Maumee-method and contained less than 0.2 ppm
toluenesulfonamide. Male and female rats were
mated after ingesting saccharin for approximately
90 days. Similar groups of rats which were exposed
to saccharin in ittero and during lactation as a result
of maternal ingestion of saccharin (F1 generation)
and later in the diet received saccharin for 127
weeks. Other rats that did not ingest saccharin
served as controls.
Eight of 45 (18%) F1 male rats had malignant
tumors and 4 of 45 (9%) had benign tumors of the
urinary bladder (Table 15). Three of38 (8%) F,, male
rats developed malignant tumors and 4 of 38 (I 1%)
developed benign tumors of the urinary bladder.
There was a metastasis to a lymph node in at least
one rat. Two rats with tumors ofthe urinary bladder
had stones and four rats without tumors had stones.
Parasites were not present in the urinary bladder.
Small numbers of F1 female rats developed tumors
of the urinary bladder (Table 16).
Male rats of the F, generation developed more
tumors of the urinary bladder than did those of the
F, generation. The tumors in the F, male rats were
more malignant and were observed earlier, 67
weeks compared to 87 weeks for F,, rats.
The increase in tumors of the urinary bladder are
highly significant in male rats of both generations
and in male and female rats of both generations
(Table 17).
Of 172 rats ingesting saccharin, 21 rats developed
tumors ofthe urinary bladder, compared to I of 163
controls (p = 0.000,00526).
In summary, male rats ingesting saccharin in the
diet developed tumors of the urinary bladder. Rats
ofthe F1 generation were more susceptible than rats
of the F0 generation.
August 1978 181Table 15. Tumors of the urinary bladder in male rats ingesting saccharin.
No. of tumors
Dose, Fo F,
mg/kg-day Benign Malignant Total Benign Malignant Total
0 1/36(3%) 0/36(0%o) 1/36(3%) 0/42(0%) 0/42(0%) 0/42(0%)
2500 4/38(11%) 3/38(8%) 7/38(19o) 4/45(9o) 8/45(18%) 12/45(27%)
(p = 0.0334) (p = 0.0670) (p = 0.003689) (p = 0.000162)
Table 16. Tumors of the urinary bladder in female rats ingesting saccharin.
No. of tumors
Dose, Fo F1
mg/kg-day Benign Malignant Total Benign Malignant Total
0 0/38(0Oo) 0138(0o) 0/38(0o) 0/47(0%) 0/47(0%) 0/47(0%)
2500 0/49(0%O) 0149(0o) 0/49(0O/o) 0/49(0%) 2/49(4%) 2/49(4%)
Table 17. Tumors of the urinary bladder in both sexes ingesting saccharin.
No. of lesions
Dose, Fo F,
mg/kg-day Benign Malignant Total Benign Malignant Total
0 1/74(1.35%) 0/74(0.00O) 1/74(1.35%) 0/89(0.00o) 0/89(0.00%) 0/89(0.00%)
2500 4187(4.00o) 3/78(3.85%) 7/78(8.97%) 4/94(4.26%) 10/94(10.64%) 14/94(14.89o)
(p = 0.0334) (p = 0.0675) (p = 0.001001) (p = 0.000054)
Chapman Study. Chapman attempted to study
the effect ofparasites upon the induction ofurinary
bladder tumors by 2-acetylaminofluorene (25). The
three strains of male and female rats used were
Griedl (Steinhilber), Long-Evans, and Fischer 344.
Some rats had urine dropped, on them in order to
infect them and others ingested 0.2% nitrofurantoin
for 8 weeks in an effort to disinfect them.
Acetylaminoflurene, in a dose of 0.5% in ground
Purina laboratory chow, was given to the rats at 4
months of age for 1 year in order to induce tumors
of the urinary bladder. Some "paired groups" of
two strains were given additional DL-tryptophan
(1%) in a further attempt to induce tumors of the
urinary bladder. An attempt was made to give some
rats indole in the diet, but this was discontinued.
Initial numbers of rats in each group were not
given, however, the results were based on the
number of animals living over 7 months, i.e., 153
rats. The 20 different groups had from 0 to 15 rats in
each group, with an average of 7.7 rats per group.
There were no control rats not receiving acetyl-
aminofluorene.
There were 5 bladder tumors: 3 of77 males (4%)
and 2 of 79 females (3%), or 5 of a total number of
156 rats (3%). One ofthe rats with a bladder tumor
also ingested tryptophan. The incidence of tumors
of the urinary bladder was assumed to be 0%o in
animals not treated with chemicals. The tumors of
the urinary bladder occurred in 5 of the 75 rats that
had parasites. Bladder stones were not observed in
rats of any group.
The results suggested that nitrofurantoin may
have decreased the incidence of liver tumors and
increased the numbers of rats with tumors of the
lung or mammary gland. Nitrofurantoin may also
have decreased the incidence of tumors of the uri-
nary bladder. Tryptophan may have decreased the
incidence of tumors of the mammary gland and
lung.
The results were furthercomplicated by problems
associated with trying to infect and disinfect rats:
"Our results in clearing infected rats of the worm
were not completely successful. Of 52 infected rats
fed nitrofurantoin in an attempt to clear them of
infection, five were still infected when examined;
only 37 of the 55 infected and untreated animals
were infected at autopsy."
"The results from attempting to infest the clean
animals were even less satisfactory. One of the 30
clean animals became infected spontaneously and
only 3 of the 25 that were exposed to infection by
feeding T. crassicauda eggs remained infected at
the end of the experiment."
The authors also speculated that the low inci-
dence oftumors ofthe urinary bladder, particularly
Environmental Health Perspectives 182in rats given tryptophan, may have been related to
the age of the rats at the start of the experiment,
about 4 months.
In summary, the incidence of acetylamino-
fluorene-induced tumors ofthe urinary bladder was
not increased significantly in rats with parasites of
the urinary bladder. Additional groups of control
rats receiving nitrofurantoin or tryptophan and not
given acetylaminofluorene are necessary to prop-
erly interpret the data.
Canadian Health Protection Branch Study
(1977). Male and female Fo Charles River
Sprague-Dawley rats, 30 days of age, 50 per group,
ingested 0, 2.5, 25, or 250 mg/kg-day of o-toluene-
sulfonamide in the diet for 142 weeks (23, 24).
The diet was adjusted weekly to maintain a constant
level of o-toluenesulfonamide. Similar groups of
rats, which were exposed too-toluenesulfonamide in
utero as a result ofmaternal ingestion, also received
the chemical in the diet for 127 weeks. The levels of
o-toluenesulfonamide were so chosen as to be equiv-
alent to levels that rats may have consumed from the
ingestion ofsaccharin-containing diets in the WARF
and FDA Studies (/9, 20).
Tumors ofthe urinary bladder were not increased
significantly in rats ingesting o-toluenesulfonamide
in the diet when compared to the controls (Tables
18, 19).
In this study, o-toluenesulfonamide did not in-
duce tumors of the urinary bladder in rats.
Mouse Studies
Study ofAllen et al. A study was carried out in
which pellets ofsaccharin and cholesterol were sur-
gically implanted in the urinary bladder of un-
specified sex and stock mice (26). Pellets weighing
between 9 and 11 mg were prepared from a mixture
of four parts cholesterol and one part saccharin.
Control mice received pellets of cholesterol only.
Pellets containing saccharin induced a significant
number of urinary bladder tumors (Table 20). Four
of 13 mice (31%) had tumors ofthe urinary bladder,
and two were carcinomas and one a papilloma (p =
0.04101). One of 24 control mice (4%) had a car-
cinoma of the bladder.
In addition, the following points concerning the
implantation of pellets into the urinary bladder of
rodents were made.
The technique of implanting pellets into the uri-
nary bladder of mice can be used to indicate
whether the carcinogenic activity is caused by the
chemical itself or by a metabolite, because the pos-
sibilities of metabolic changes occurring in the
bladder are limited.
The urinary bladder of mice seem to be more re-
sistant to the apparent carcinogenic action of inert
solids than are those of rats, so that mice may be
more suitable animals for use with the implantation
technique.
Although implantation of pellets of cholesterol
only induces some tumors, the carcinogenicity of a
particularchemical can be evaluated by the increase
in the tumor incidence after implantation of a mix-
ture of chemical and cholesterol.
The induction of tumors of the urinary bladder is
related to the size of the pellet; therefore, the inci-
dence oftumors in controls can be decreased by the
use of smaller pellets.
In this study, saccharin induced tumors of the
urinary bladder in mice. Most of the tumors were
malignant.
Study ofBryan et al. Bryan et al. studied the
carcinogenicity of sodium saccharin in mice by im-
planting pellets of saccharin and cholesterol in the
urinary bladder (27). Pellets composed of sodium
saccharin and cholesterol (1:4 mixture), weighing
Table 18. Tumors of the urinary bladder in male rats ingesting
o-toluenesulfonamide.a
No. of tumors
Dose, Fn F1l
mg/kg-day Benign Malignant Total Bening Malignant Total
0 1/50 0/50 1/50 0/50 0/50 0/50
2.5 1/50 0/50 1/50 0/50 1/50 1/50
25 0/50 0/50 0/50 1/50 0/50 1/50
250 1/50 0/50 1/50 0/50 0/50 0/50
a Figures not corrected for survival time.
Table 19. Tumors of the urinary bladder in female rats ingesting
o-toluenesulfonamide.a
No. of tumors
Dose, Fo Fl.
mg/kg-day Benign Malignant Total Benign Malignant Total
0 0/50 0/50 0/50 0/50 0/50 0/50
2.5 1/50 0/50 1/50 2/50 0/50 2/50
25 0/50 0/50 0/50 0/50 0/50 0/50
250 0/50 0/50 0/50 0/50 0/50 0/50
a Figures not corrected for survival time.
Table 20. Number of mice treated with saccharin with tumors of
the urinary bladder.
No. of mice with tumors
Treatment Benign Malignant Combined
Cholesterol 0/24(0o) 1/24(4%) 1/24(4%)
Saccharin + 1/13(8%) 3/13(23%) 4/13(31%)
cholesterol (p = 0.04101)
August 1978 18320-24 mg, were surgically placed in the urinary
bladder lumens of two groups of 100 female Swiss
mice 60-90 days old. Pure cholesterol pellets were
placed in the urinary bladder of two groups of 100
mice each. This study was conducted at the same
time as that reported previously with sodium cy-
clamate (29); therefore, the control groups given
cholesterol alone were the same for both studies. To
estimate the probable exposure of the urinary blad-
der to saccharin, pellets were removed from some
mice at various times after implantation and the
quantity of saccharin remaining in the pellets was
measured (24). Surviving mice were killed after 13
months. All organs except the brain were inspected
grossly, and histologic examination of representa-
tive tumors was done.
Of the saccharin, 50% had disappeared after 5.5
hr and 99% by 1.5 days. The first bladder carcinoma
was observed in a mouse treated with saccharin that
died after 293 days. Most mice survived for 326
days or longer. Mice exposed to sodium saccharin
had significantly higher incidences ofcarcinomas of
the urinary bladder (47% and 52%) than did the
controls (13% and 12%) (Table 21). No other tissues
of mice exposed to sodium saccharin were reported
to have a tumor incidence significantly different
from the controls; however, those data were not
given.
Histologically, all of the transitional cell car-
cinomas infiltrated into the subepithelial connective
tissue, and some infiltrated into the muscular wall,
penetrated through the serosal layer ofthe bladder,
or had local metastases in the pelvis.
In addition, the following points were made.
The carcinomas in mice exposed to sodium sac-
charin were often seen grossly and sometimes filled
the lumen, were frequently multiple within the same
bladder, were often more invasive into muscle (p =
<0.009), and were often undifferentiated and highly
anaplastic.
The degree of histologic malignancy observed in
the carcinomas of the urinary bladder induced by
sodium saccharin was more severe than that seen in
carcinomas induced by sodium cyclamate.
The carcinomas ofthe urinary bladder induced in
mice by sodium saccharin were comparable to those
Table 21. Number of mice treated with sodium saccharin with
carcinoma of the urinary bladder.
No. of mice with carcinomas
Treatment Group I Group 2 Groups combined
Cholesterol 8/63(13%) 5/43(12%) 13/106(12%)
Saccharin + 31/66(47%) 33/64(52%) 64/130(49o)
cholesterol (p = 0.000027) (p = 0.000029) (p =0.000000003)
induced in mice, rats, and dogs by feeding the po-
tent urinary bladder carcinogen N-[4-(5-nitro-2-
furyl)-2-thiazolyl] formamide, as well as other car-
cinogens.
In conclusion, female mice with pellets ofsodium
saccharin and cholesterol implanted in the urinary
bladder developed highly significant incidences of
undifferentiated and invasive carcinomas ofthe uri-
nary bladder.
Bio-Research Consultants. Bio-Research Con-
sultants carried out two separate studies with the
same experimental design on the chronic effects of
sodium saccharin in mice (14). Albino male and
female mice (derived from HaM/ICR mice), 25 in
each group, ingested 0%, 1%, or 5% sodium saccha-
rin in the diet for 104 weeks or longer. The saccha-
rin (Merck or Monsanto) was stated not to contain
impurities. There were two groups of males and
females for each dose level of saccharin.
Tumors of the urinary bladder were found in two
male mice and papillary hyperplasia in three male
mice ingesting saccharin. There was a tumor of the
urinary bladder in one control mouse.
The results of this study suggest that larger num-
bers ofmice ingesting saccharin are needed in order
to determine its carcinogenicity for the urinary
bladder.
Other Studies. Kroes, et al. gave Swiss-SPF
male and female mice, 50 ofeach sex pergroup, %o,
0.2%, or 0.5% saccharin in the diet for 21 months
(30). Carcinomas of the urinary bladder were ob-
served in one male mouse ingesting 0.2% and one
male mouse ingesting 0.5% saccharin. Calculi were
not associated with the carcinomas.
Amyloidosis of the kidney was increased in
females receiving 0.5% saccharin.
The results ofthis study suggest that saccharin is
carcinogenic for the urinary bladder of male mice.
Saccharin should have been administered for a
longer period of time. Amyloidosis and other dis-
eases interfered with the health and lifespan and
with the development of neoplasms.
Summary
The findings are summarized in Table 22. In the
earliest studies, small numbers ofrats ingesting sac-
charin in the diet developed tumors of the urinary
bladder. These studies did not demonstrate that sac-
charin was not carcinogenic for the urinary bladder,
but strongly indicated that ifstudies were done using
large numbers ofrats saccharin mostlikely would be
carcinogenic for the urinary bladder. There was no
Environmental Health PerspectivesTable 22. Tumors of the urinary bladder in rats ingesting saccharin.
Number with tumors
Study Year Dose, % Animal Control Treated p
Lessel 1959 5.0 Rat (female) 0/20 2/20 (10o)
Litton 1972 5.0 Rat (female) 0/20 1/26 (3.8%)
FDA 1973 7.5 Rat (female) 0/24 4/31 (12.9%W) 0.09226
Rat (male) 1/25 (4%) 7/23 (30.4%) 0.01754
Rat (both sexes) 1/49 (2%) 11/59 (18.6%) 0.005319
Warf 1973 0.05 Rat (female) 0/17 1/17 (5.9%) 0.500000
5.0 Rat (male) 0/16 7/16 (44%) 0.003399
Rat (both sexes) 0/33 8/33 (24.2%) 0.002417
Munroe 1973 0.2 Rat (female) 0/56 1/56 (1.8%)
(Canada) 0.2 Rat (male) 0/57 1/51 (2%)
2.0 Rat (male) 0/57 2/52 (3.8%)
Rat (both levels, 0/113 4/159(2.5%) 0.11493
both sexes)
Hicks 1975 8 Rat (both sexes) 0/600 (0%) 3/138(2%)
Canada 1977 5.0 Rat (male) 1/78 (1.3%) 19/83 (22.9%) 0.00001263
Rat (female) 0/85 2/89 (2.2%) 0.260
Rat (both sexes) 1/163 (0.6%) 21/172(12.2%) 0.00000526
evidence in these early studies thatthe tumors ofthe
urinary bladder were caused by stones or by para-
sites in the urinary bladder and not by saccharin.
There are no data showing that stones and parasites
influence the induction of tumors of the urinary
bladder in rats ingesting chemicals.
Recent studies have shown that saccharin is defi-
nitely carcinogenic for the urinary bladder in rats.
Male rats are more susceptible than female rats.
Rats of the F1 generation develop tumors more
readily than do those of the Fo generation. The car-
cinomas are preceded by the development of mild,
moderate, and severe hyperplasia, polypoid
hyperplasia or hyperplastic nodules. Rats ingesting
saccharin with carcinomas of the urinary bladder
did not have bladder stones and rats with bladder
stones did not have hyperplastic or neoplastic le-
sions of the urinary bladder. Neoplasms of the uri-
nary bladder sometimes developed prior to the de-
velopment of bladder stones in rats ingesting sac-
charin that were pretreated with nitrosamine. Para-
sites were not present in the urinary bladder of rats
ingesting saccharin that had tumors ofthe bladder.
Those studies, indicating that saccharin most
likely was carcinogenic for the urinary bladder in
rats, were supported by the development of car-
cinomas of the urinary bladder in mice with surgi-
cally implanted saccharin cholesterol pellets. The
results were so convincing that the route of admin-
istration of saccharin should not have been consid-
ered as not appropriate. Carcinomas of the urinary
bladder ofnitrosamine-pretreated rats ingesting sac-
charin also added to the accumulating evidence that
saccharin was carcinogenic.
Rats ingesting saccharin developed chronic renal
disease and tumors or polyps of the renal pelvic
mucosa, a finding observed in the first study. It is
apparent that a relationship exists between the dose
of saccharin, chronic renal disease, renal pelvic
tumors, and tumors of the urinary bladder; how-
ever, renal lesions in more recent studies have not
been adequately examined. It appears that chronic
renal disease results from the administration of low
doses of saccharin and that tumors of the renal pel-
vis and urinary bladder develop with the higher
doses. At lower doses saccharin may not reach the
urinary bladder and could not be expected to induce
hyperplastic or neoplastic lesions.
Renal pelvic lesions observed in the first, as well
as in later, rat studies should have alerted inves-
tigators to the probability that tumors would also
develop in the similar epithelium of the urinary
bladder. These lesions should be considered as pre-
neoplastic and as having the potential to become
carcinomas.
Recent studies in rats ingesting saccharin with
tumors ofthe urinary bladder also took into consid-
eration other criticisms. Control rats were given
sodium carbamate (at the same level as that in-
gested by the rats ingesting 5% sodium saccharin)
and the saccharin contained fewer or no impurities.
o-Toluenesulfonamide, a contaminant of saccharin
in the earlier studies, is not carcinogenic for the
urinary bladder of rats.
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Rat Studies
Wisconsin Alumni Research Foundation
(WARF) Institute Study. Male and female
Sprague-Dawley (F1) weanling rats, 20 per group,
ingested 0%, 0.05%, 0.5%, or 5% sodium saccharin
in Purina laboratory chow for 100 weeks (19).
Female rats developed increased incidences of
both benign and malignant tumors of the reproduc-
tive system (ovary and uterus), which were dose
related (Table 23). Such tumors were present in 6 of
20female rats (30%o) ingesting 5% sodium saccharin,
compared to 1 of 17 control female rats (6%) (p =
0.0716).
Malignant tumors were also increased, and they
were dose related. There were 6%, 13%, and 20%
(p = 0.0734) in the saccharin-treated rats at the
three doses; whereas none were seen in control
females. The malignant tumors were squamous cell
carcinomas of the uterus and carcinomas of the
ovary.
In summary, the incidences of malignant tumors
ofthe reproductive system were increased in female
rats ingesting saccharin. Malignant tumors were
present in the uterus and ovary.
FDA Study (1973). The FDA study used
weanling Charles River Sprague-Dawley male and
female rats ingesting 0o, 0.01%, 0.1%, 1%, 5%, or
7.5% sodium saccharin in Purina laboratory chow
for approximately 28 months (31).
Rats received a thorough gross examination.
Complete necropsies with histological examination
were done unless autolysis was too advanced. Only
tumors of the mammary gland were studied his-
tologically, i.e., routine sections of mammary
glands were not done in all rats.
Mammary tumors were seen in rats ofboth sexes
living for 18 months or longer, and a few were also
observed before 18 months (Tables 24 and 25). There
were often two or more mammary tumors in female
Table 23. Tumors ofthe reproductive system (uterus and ovary) in
female rats ingesting saccharin.
No. rats
With With
Dose, % benign tumors malignant tumors total
0 1/17( 6%) 0/17( 0%) 1/17( 6%)
0.05 0/17( 0%o) 1/17( 6%)a 1/17( 6%)
0.5 1/15( 7%) 2/15(13%X)- 3/15(20)
5 2/20(10%) 4120(20%)b 6/20(30%o)
(p = 0.0734) (p = 0.0716)
a Squamous cell carcinomas of the uterus.
b Carcinomas of the ovary.
Table 24. Tumors of the mammary gland in male rats ingesting
saccharin.
No. rats with mammary gland tumors
Dose, % One/rat Two or more/rat Total
0 5/29(17%) 1/29( 3%) 6/29 (20o)
0.01 8/25(32%) 6/25(24%) 14/25 (56%)
0.1 9/27(33%) 0/27( %o) 9/27 (33%)
1.0 8/27(30o)- 0/27( 0%) 8/27 (30o)
5.0 7/25(28%) 0/25( 0o) 7/25 (28%)
7.5 7/24(29o) 0/24( 0o) 7/24 (29o)
45/128(35%)
(p = 0.0988
a One rat had one mammary gland tumor prior to 18 months.
Table 25. Tumors of the mammary gland in female rats ingesting
saccharin.
No. rats with mammary gland tumors
Dose, % One/rat Two or more/rat Total
0 5/26(1Wo)- 1/26( 4%) 6/26(23%)
0.01 8/30(27%) 6130(20o) 14/30(47%)
0.1 9/34(26%) 4/34(12%) 13/34(38%)
1.0 8/30(27%) 4/30(13%)b 12/30(40o)
5.0 7/27(26%) 5/27(18%)b 12/27(44%)
7.5 7/32(22%) 2/32( 6%) 9/32(28%)
0.01-7.5 60/153(39o)
(p = 0.0874)
a One rat had one mammary gland tumor prior to 18 months.
b Two rats had two or more mammary gland tumors before 18
months.
rats ingesting saccharin, whereas untreated female
rats usually had one mammary gland tumor. The
incidence of mammary gland tumors was highest in
rats ingesting 0.01% saccharin; 56% in saccharin-
treated males (p = 0.0038), 20% in untreated males,
47% in treated females, and 23% in untreated
females.
Sixty of 153 saccharin-treated female rats (p =
0.0874) and 45 of 128 male rats ingesting saccharin
(p = 0.0998) developed tumors of the mammary
gland.
It should be noted the incidence of tumors of the
mammary gland would most likely have been higher
if mammary glands of all rats had been examined
histologically. There may have been tiny tumors
("microscopic") that were not seen on gross
examination.
Furthermore, a thorough analysis of the benign
versus malignant tumors of the mammary gland is
needed. Malignant tumors generally occur more
often in chemically treated rats than in untreated
rats.
In summary, the incidences of tumors of the
mammary gland were increased in rats ingesting
saccharin. This finding is significant because sac-
charin was carcinogenic for the mammary gland and
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Munroe et al. Study. Munroe et al. (15) ob-
served a sarcoma of the uterus in a female rat and
adenocarcinomas in two female rats given 2430 mg
saccharin/kg-day.
Mouse Studies
National Institute of Hygienic Sciences (To-
kyo). Male and female dde strain inbred mice in-
gested sodium saccharin in the diet. Mice ingested
0%, 0.2%, 1%, or 5% for 21 months (32). Many
details are missing in the brief report.
There were increased numbers of tumors in the
reproduction system (ovary and mammary gland).
Six of 9 tumors (67%) in female mice ingesting
0.2%, 7 of 12 tumors (58%) in mice ingesting 1%,
and 10 of 13 tumors (77%) in mice ingesting 5%
saccharin were in the reproductive system. No dis-
tinction was made between benign and malignant
tumors.
The number ofmice with tumors ofthe ovary can
be analyzed; however, the number of mice with
tumors of the reproductive system cannot be
analyzed because one mouse may have had more
than one tumor.
Female mice ingesting saccharin had an increase
incidence of tumors ofthe ovary, and the incidence
was highest at the two largest doses (Table 26).
Sixteen of 41 mice (40%) ingesting saccharin de-
veloped tumors of the ovary (p = 0.00347).
In summary, the number oftumors in the reproduc-
tive system was increased in saccharin-treated
female mice. The number of mice with ovarian
tumors was also increased significantly in treated
mice.
Bio-Research Consultants Study. Bio-
Research Consultants carried out two separate
studies with the same experimental design on the
chronic effects of sodium saccharin in mice (14).
Albino male and female mice, 25 in each group,
ingested 0%, 1%, or 5% sodium saccharin in the diet
for 104 weeks or longer. There were two groups of
males and females for each dose level of saccharin.
Table 26. Tumors of the ovary in female mice ingesting saccharin.
Dose, % No. of mice with tumors
O 0/14(0o)
0.2 3/18(17%)
1.0 7/11(64%)
5.0 6/12(50%o)
All doses 16/41(40%)
(p = 0.00347)
The data from this study were analyzed at the
NCI; it was concluded that "'for tumors of the
uterus among female mice the life table analysis re-
veals a significant effect in the high dose group for
females" (13).
Summary
Saccharin is carcinogenic for the reproductive
system in female rats and mice and mammary gland
in male rats.
Female rats ingesting saccharin developed in-
creased incidences of tumors of the reproductive
system, which were dose related. Both male and
female rats ingesting saccharin developed increases
in tumors of the mammary gland, as well as more
tumors per rat. Saccharin-treated female mice had
an increase in ovarian and uterine tumors.
Tumors Involving the
Hematopoietic System
Rat Studies
FDA Study (1948-1949). Osborne-Mendel
male and female weanling rats, 10 of each sex per
group, ingested 0%, 0.01%, 0.1%, 0.5% 1%, or 5%
saccharin in the diet (33). Saccharin was mixed with
ground commercial rat biscuits with 1% added
cod-liver oil. Rats were kept in individual cages and
given free access to the diets. Rats were killed after
2 yr. Detailed histological examinations were done
for some rats, but others were limited to liver, kid-
ney, and testis. Urinary bladder was not routinely
examined.
'Lymphosarcoma" was present in the lung of 7
of20 rats ingesting 5% saccharin. Both thoracic and
abdominal lymphosarcomas were observed in 4 of
the 7 rats. Three occurred in animals after 102
weeks. Lesions in rats were not attributed to the
lower doses of saccharin. No mention is made of
tumors in control rats.
Saccharin induced lymphosarcomas in rats.
Other results are not complete because of limited
histological examinations, failure to separate results
by sex, and lack of correction for survival time.
Long and Haberman (FDA Study 1948-
1949). Long and Haberman, with the assistance
of Stewart, reviewed the available data and micro-
scopic studies from the long-term rat feeding study
on saccharin done at the FDA (8). Groups of 3-
week-old Osborne-Mendel rats, 10 of each sex per
group, received 0%, 0.01%, 0.1%, 0.5%, 1%, or 5%
saccharin in the diet for 2 yr.
Lymphosarcomas were observed in increased in-
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No. of lymphosarcomas
Dose, % Thorax Abdomena Total
O 0/20(0o) 0/20(0%o) 0/20(0o)
0.01 8/14(57%) 0/14(0%7o) 8/14(57%)
0.1 5/16(31%) 0/16(0%o) 5/16(31%)
0.5 2/15(13%) 0/15(0%o) 2/15(13%)
1 1/18(6%) 0/18(0'o') 1/18(6%)
5 7/17(41%)b 4/17(24%)b 7/17(41%)
Total 25/80(31.25%)
(p = 0.000053)
a Rats with lymphosarcomas of the abdomen also had lym-
phosarcoma of the thorax.
b One rat also had lymphocytic leukemia.
cidences in the thoracic and abdominal cavity of
saccharin-treated rats when compared to the con-
trols (p = 0.000053) (Table 27). It should be noted
that untreated and treated rats ofall groups had only
a slight degree of acute and chronic pneumonia.
The increased incidences of lymphosarcoma of
the thorax in rats at the 0.01% and 5%, as well as for
both abdominal and thoracic lymphosarcomas in
rats at the 5% dose of saccharin, are highly signifi-
cant when compared to the control rats in the sac-
charin study. The incidences are significant also
when compared with the pooled controls, those
used for the saccharin study, and the controls for
three other artificial sweetners. Abdominal lym-
phosarcomas were found only in rats treated at the
5% dose level and not in matched or pooled con-
trols. There is a progressive dose-related increase in
the incidence ofthoracic lymphosarcomas from the
1% to the 0.01% treated rats, i.e., from 6% to 57%.
Not only was there an increased incidence of
lymphosarcomas in the rats receiving 5% saccharin,
but there was also an increased incidence of
hyperplasia (increased cellularity) of the bone mar-
row in those rats (91% versus 66% to 83% for the
various control groups).
It was reported that there were no sex differences
in the incidences of thoracic tumors; however, in
some groups on control rats used at FDA fortesting
of chemicals, the incidence was as low as 0o in
untreated male rats and somewhat higher in un-
treated female rats. If that is the case for the con-
trols in this study, the incidences in the saccharin-
treated male rats could even be higher than those
given here for males and females combined.
In conclusion, saccharin is a carcinogen for lym-
phocytic tissue in the thoracic cavity, as well as in
the abdominal cavity. Rats also had hyperplasia of
the bone marrow.
Study of Schmahl. Schmahl gave 70- to 90-
day-old male and female rats 0%, 0.2%, or 0.5%
sodium saccharin in the diet for a lifetime (11). Rats
also received the much higher doses of7% or 5% of
cyclamate. This strain of rats was described as
being susceptible to the development of tumors of
the urinary bladder.
Histologic examination of tissues, with the ex-
ception of the bladder, were done "'when organs
seemed pathologically changed." Only grossly ob-
servable tumors, and not microscopic tumors, were
examined. Every rat in the study was considered at
risk, i.e., survived long enough to develop a tumor.
The tumor incidences for the sexes were combined
rather than being analyzed separately.
Tha analysis of malignant tumors in the various
groups of rats is complicated by the 12% incidence
ofmalignant tumors in the control rats. Lymphomas
and leukemias were found in 14% oftreated rats and
4% of control rats.
It is well known that animals that die early from
infectious diseases or that are not healthy develop
fewer, ifany, tumors. The statement was made that
"most ofthe animals died from typical infections of
the respiratory tract." Indeed, another study of
carcinogenicity of a chemical from the same Insti-
tute went even further to say that the low incidence
of tumors might be related to the high incidence of
infections (34).
In summary, rats ingesting sodium saccharin,
particularly at the 0.5% level, developed slightly in-
creased incidences of lymphomas and leukemia.
The results obtained were under the conditions of
this experiment (incomplete histology, failure to
separate the results by sex, including all rats at risk
for the development of tumors, and using a strain
with a high incidence of "spontaneous" tumors).
Furthermore, "most of the animals died from typi-
cal infections of the respiratory tract."
Study ofMunroe et al. Munroe et al. studied
the carcinogenicity ofcommercial saccharin in male
and female Charles River weanling rats weighing
50-60 grams (15). Groups of 60 male and 60 female
rats were given sodium saccharin, 0, 90, 270, 810, or
2430 mg/kg-day in a synthetic diet for 26 months.
The urinary bladder, as well as "other grossly ab-
normal organs," were examined histologically.
Particular attention was given to regional pelvic
and lower abdominal lymph nodes because of the
possibility of metastases from urinary bladder
tumors; however, only other grossly enlarged
lymph nodes or enlarged spleens were examined
histologically.
There were increased incidences oflymphoma or
leukemia in the saccharin-treated male rats (Table
28). Of control male rats, 3.5% developed lym-
phoma or leukemia, whereas 9% of the 270 mg/kg
dose level male rats, and 13% of the 2430 mg/kg
dose level developed lymphoma or leukemia. Large
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leukemia.a
No. rats with
Dose, mg/kg lymphoma or leukemia
0 2/57(3.5%)
90 2/51(4%)
270 5154(9o)
810 2/5 (4%)
2430 7/54(13%)
(p = 0.06873)
a The effective number of rats, or rats that survived long
enough to develop tumors, is not given. Only about 40 rats per
group were alive at 18 months.
numbers ofrats ofall groups were also diagnosed as
having "chronic lymphadenitis/reactive hyper-
plasia."
In this study, male rats ingesting saccharin de-
veloped slightly increased incidences of lymphoma
or leukemia.
Summary
Saccharin is carcinogenic for lymphocytic tissue
in rats. Lymphosarcomas were observed in signifi-
cantly increased incidences in the thoracic and
abdominal cavity of saccharin-treated rats. Rats in-
gesting saccharin developed slightly more lym-
phomas and leukemias than did untreated rats.
Tumors Involving the Lungs and
the Vascular System
Rat Studies
FDA Study (1948-1949) and Long and Haber-
man. Lymphosarcomas were observed in the lung
and abdominal cavity of saccharin-treated rats (8,
33). Lymphosarcomas ofthe lung were increased in
rats ingesting 0.01% or 5% saccharin, when com-
pared to the control rats, as well as in all treated
rats.
These tumors have been discussed with tumors of
the hematopoietic system.
Mouse Studies
Bio-Research Consultants. Bio-Research Con-
sultants carried out two separate studies with the
same experimental design on the chronic effects of
sodium saccharin in mice (14). Albino male and
female mice (derived from HaM/ICR mice), 25 of
each sex in each group, ingested 0o, 1%, or 5%
sodium saccharin in the diet for 104 weeks or
longer. The saccharin (Merck or Monsanto) was
stated to contain no impurities. There were two
groups of males and females for each dose level of
saccharin.
Animals dying during the first 6 months were not
autopsied. Thereafter, complete gross autopsies
were done unless mice were too autolyzed for his-
tological examination. Histopathological examina-
tion was done on "grossly pathological organs ofall
animals and on all vital organs in at least 12 animals
in each group."
There were increased incidences oftumors ofthe
lung in the male mice ingesting 1% sodium saccha-
rin (p = 0.006566). Benign and malignant tumors of
the lung should also be evaluated, because malig-
nant tumors are more likely to be seen in treated
mice and benign tumors in controls. Four of 14 male
mice (29o) in one group had carcinomas ofthe lung,
compared to 1 of 19 controls (5%) (Table 29).
There was an increase in the incidence of vascu-
lar tumors in some groups of male mice ingesting
sodium saccharin. The mice ingesting 5% had 32%
hemangiomas and 11% hemangiosarcomas (p =
0.0327); those ingesting 1% had 7% hemangiosar-
comas, compared to 5% hemangiomas and 0%
hemangiosarcomas in the control male mice (Table
30).
In summary, male mice ingesting saccharin had
increased incidences of vascular tumors, and of
tumors ofthe lung. Vascular tumors in treated mice
were sometimes malignant.
Summary
Saccharin is carcinogenic for the lung and vascu-
lar system in mice. Male mice ingesting saccharin
had increased incidences of vascular tumors and of
tumors ofthe lung. Vascular tumors in treated mice
Table 29. Tumors of the lung in male mice ingesting
sodium saccharin in both studies.
Dose, No. of mice
5% Group I Group 2 Total
0 2/19(11%)
1 6/14(43%) 8/15(53%) 14/29(48%)
(p = .006566)
5 4/15(27%) 5/19(26%o) 9/34(27%)
Table 30. Tumors of the vascular system in male mice ingesting
sodium saccharin in both studies.
Dose, No. of mice
So Group I Group 2 Total
0 1/19(5%)
1 1/14(7%) 1/15(7%) 2/29(7%)
5 2/15(13%) 8/19(42%) 10/34(29o)
(p = 0.0327)
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developed lymphosarcomas of the lung.
Tumors Involving Squamous
Epithelium
Rat Studies
Bio-Research Consultants carried out two sepa-
rate studies with the same experimental design on
the chronic effects of sodium saccharin in rats (14).
CDI random-bred male rats, 25 of each sex in each
group, ingested 9%, 1%, or 5% sodium saccharin in
the diet for 104 weeks or longer. The saccharin
(Merck or Monsanto) was stated not to contain im-
purities. There were two tumors ofthe forestomach
and one of the skin in rats on the high dose of
sodium saccharin (12%) and two tumors of the
stomach in rats on the low dose (8%), whereas con-
trol rats did not develop such tumors. There were
tumors in the stomach and skin ofsaccharin-treated
rats; none were seen in controls. There also were
tumors in the stomach and skin of mice given sac-
charin at the same time.
Tumors of the skin were also observed in rats in
the National Institute of Hygienic Sciences study
(39).
Mouse Studies
Salaman and Roe Tumor-Initiating Study in
Mice. There are chemicals which, though not car-
cinogenic for mouse skin, produce changes in the
skin that develop into tumors after a subsequent
short course ofcroton oil applications (35). Salaman
and Roe studied the initiating action ofsaccharin on
the induction of skin tumors by croton oil. "S"
strain mice, 20 per group, were used.
Saccharin was administered (8% solution in
acetone or methanol) by skin painting, as was cro-
ton oil. Ten "thrice weekly" dermal applications of
saccharin were given for a total dose of 0.24 g.
There was a 25-day interval after the first applica-
tion of test substance and the first application of
croton oil. Weekly applications of 0.25% croton in
acetone were given for 18 weeks.
At the end ofthe treatment with croton oil, 7 of20
mice (35%) had skin tumors and a total of 14 tumors
was found. There were a few papillomas ofthe skin
in mice in two of three control groups (1 of 17, 4 of
19, and 0 of 17, or 5 of53). The authors pointed out:
"'Although treatment with croton oil without an ini-
tiator gives some skin tumors in mice, the car-
cinogenicity of an initiator can be evaluated by the
increase in the tumor incidence after treatment with
an initiator."
In summary, saccharin caused skin tumors to de-
velop in mice when its application was followed by
treatment with croton oil.
Bio-Research Consultants. Bio-Research Con-
sultants carried out two identical studies with the
same experimental design on the chronic effects of
sodium saccharin in mice (14). Random-bred albino
male and female mice, 25 in each group, ingested
0%, 1%, or 5% sodium saccharin in the diet for 104
weeks or longer. The saccharin (Merck and Mon-
santo) was stated as containing no impurities. There
were two groups ofmales and females for each dose
level of saccharin.
Male mice developed some tumors of the
stomach or skin. Four of 29 mice (14%) ingesting
1% sodium saccharin had such tumors, compared to
0% ofthe control mice. One tumor was a squamous
cell carcinoma of the forestomach and another an
adenocarcinoma of the stomach in mice ingesting
the low dose of saccharin. Occasional mice in both
treated and control groups had atypical hyperplasia
of the glandular mucosa of the stomach, but num-
bers were not given and its significance cannot be
evaluated.
In this study, tumors of the stomach and skin
were present in some mice ingesting saccharin, a
finding similar to that in rats given saccharin at the
same time.
Roe et al. TumorPromoting Study. This study
was concerned with the effect of sweeteners on
benzopyrene-induced tumors of the forestomach in
female albino mice (36). Mice, 50 per group, re-
ceived gastric instillation of 50 ug of BP in 0.2 ml
PEG after overnight starvation. After 7 days, mice
ingested 5% saccharin in the diet until they were
killed 18 months after receiving benzopyrene. Con-
trols received PEG only, followed by saccharin.
Because of a misunderstanding, mice were not
allocated randomly to the eight treatment groups.
The oldest, and therefore heaviest mice, were in-
cluded mainly in the control groups (groups 1 and 2)
while the lightest and youngest mice were allocated
to test groups 3-8.
Necropsis were carried out on mice killed or
found dead. All tumors or lesions suspected of
being tumors, were studied histologically.
In this study, saccharin did not have a tumor-
promoting effect on tumors of the forestomach in-
duced by benzopyrene.
Summary
Rats and mice ingesting saccharin tended to have
tumors of the skin or stomach; whereas none were
seen in untreated controls. Saccharin was a tumor
initiator, i.e., skin tumors developed in mice when
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Tumors Involving All Organs
Rat Studies
Wisconsin Alumni Research Foundation
(WARF) Institute Study. The WARF Institute
(International Sugar Research Foundation) de-
scribed the results of a study on Sprague-Dawley
(F1) weanling rats weighing 45-55 g (19). F1 were the
litters of female rats given saccharin. Treated rats
were exposed to saccharin from inception. Male
and female rats, 20 per group, ingested 0%, 0.05%,
0.5%, or 5% sodium saccharin in Purina laboratory
chow ad libitum for 100 weeks. Sodium saccharin
was obtained from Mallinkrodt Chemical Works.
Purina laboratory chow contained 23% protein,
4.5% fat, 6.0% crude fiber, and 9.0% ash. Rats were
housed in metal screen bottom cages. Most tissues
were sectioned histologically, with the exception of
mammary gland and pituitary, unless they had
grossly observable tumors.
The report concluded that there were increased
incidences of benign and malignant tumors, as well
as malignant tumors, in male rats ingesting 5%
sodium saccharin. Fourteen of 16 rats (87%) in-
gesting saccharin developed tumors, compared with
3 of 16 control rats (19%) (p = 0.000122). Malignant
tumors were found in 11 of 16 treated rats (69%) and
1 of 16 control rats (6%) (p = 0.000318) (Table 31).
The incidence of malignant tumors was also
slightly increased in female rats ingesting 5%
sodium saccharin (45%); however, the incidence of
malignant tumors in control rats was 23%.
The conclusions stated that "ofthe tumors found,
the adenomas and adenocarcinomas of the pitui-
tary, adenomas of the thyroid, squamous cell car-
cinomas of the uterus, and transitional cell car-
cinomas of the urinary bladders were higher in the
test than in the controls . . ." Squamous cell car-
cinomas ofthe uterus, carcinomas ofthe ovary, and
transitional cell carcinomas of the urinary bladder
were found only in the treated rats and not in the
untreated rats. There was a dose-related response
for carcinomas of the reproductive system.
Table 31. Incidence of benign and malignant tumors in male rats
ingesting saccharin.
Dose, No. of rats
5%o Benign tumors Malignant tumors Total withtumors
0 2/16(13%) 1/16(6%) 3/16(19o)
5 3/16(19%o) 11/16(69%o) 14/16(87%)
(p = 0.000318) (p = 0.000122)
In conclusion, sodium saccharin is carcinogenic
in male rats. There were significant increases ofbe-
nign and malignant tumors and of malignant tumors
only. There also were carcinomas of the reproduc-
tive system, for which there was a dose-related re-
sponse in treated female rats.
FDA Study (1973). Male and female Charles
River Sprague-Dawley rats, F1 generation, 48 per
group, ingested 0%, 0.01%, 0.1%, 1%, 5%, or 7.5%
sodium saccharin (Monsanto) in the diet (20). Some
rats were killed after 14 and 18 months, and the
remaining rats after 28 months. Control rats were
given a diet containing sodium carbonate at the
same level as that ingested by the rats ingesting 5%
sodium saccharin. Rats given 0.01% saccharin
gained more weight than control rats or rats receiv-
ing the other doses of saccharin.
There were increased incidences of malignant
tumors at all sites in rats ingesting the higher doses
of saccharin for 24 months or more (Table 32). The
tumors were related to the dose of saccharin.
Malignant tumors were found in 8 of 26 male rats
(36%) ingesting 7.5% saccharin compared to 2 of29
control male rats (7%) (p = 0.025); 7 of 29 female
rats (24%) given 5% (p = 0.0327); and in 9 of 32
female rats (28%) given the 7.5% (p = 0.0131),
compared to 1 of 27 female control rats (40%).
If all saccharin-treated rats are considered to-
gether, 16% oftreated male rats compared with 7%
of untreated males, and 17% of treated female rats
and 4% of control females, had malignant tumors.
Tumors were found in the urinary bladder, mam-
mary gland, and in other organs as well.
In summary, saccharin caused an increase in
malignant tumors at all sites in male and female rats
ingesting saccharin, particularly at the highest
doses.
Bio-Research Consultants Study. Bio-Re-
search Consultants carried out two separate studies
with the same experimental design on the chronic
effects of sodium saccharin in rats (Charles River
derived from Sprague-Dawley) (14). The only vari-
able in the two studies was the source ofsaccharin.
CDI random-bred male rats, 25 in each group, in-
gested 0o, 1%, or 5% sodium saccharin in the diet
for 104 weeks or longer. The saccharin (Merck or
Monsanto) was stated not to contain impurities.
Animals dying during the first 6 months were not
necropsied. Thereafter, complete gross necropsies
were done unless rats were too autolyzed for his-
tological examination. Histopathological examina-
tion was done on "grossly pathological organs ofall
animals and on all vital organs in at least 12 animals
in each group." Neck organs were not included in
the tissues examined.
There was an increased mortality after 1 year in
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No. of rats with tumors
Dose, % Male rats Female rats Both sexes with tumors
0 2/29(7%) 1/27(4%) 3/56(5.4%)
0.01 2/28(7%) 3/30(10%S) 5/58(8.6%)
0.1 5/29(14%) 3/32(9%) 8/61(13.1%)
1 3/28(11%) 5/32(16%)p = 0.141 8/60(13.3%)p = 0.124997
5 4/24(17%o) p = 0.247 7/29(24%) p = 0.0327 11/53(20.8%) p = 0.016050
7.5 8/26(36%o) p = 0.025 9/32(28%) p = 0.013 1 17/58(29.3%) p = 0.000647
All levels 22/135(16.3%) 27/155(17.4%) 49/290(16.90%)
(p = 0.155760) (p = 0.051257) (p = 0.015698)
one group of saccharin-treated male rats. Occa-
sional high calcium and phosphorus values were
found in some rats.
If tumors in organs other than the pituitary, a
commonly occurring tumor in control rats of this
strain, are considered, 17 of 28 male rats (61%) in-
gesting the low dose of sodium saccharin had
tumors; whereas 4 of 16 control male rats (25%) had
tumors (p = 0.02454) (Table 33). Seven of 28 male
(29%o) on the low dose of sodium saccharin had
malignant tumors compared to 2 of 16 control rats
(12%).
In this study, tumors in organs other than the
pituitary, a tumor commonly seen in controls, were
increased in rats on the low dose of saccharin.
There were tumors in the stomach and skin of
saccharin-treated rats; whereas none were seen in
controls. There also were tumors in the stomach
and skin of mice given saccharin at the same time.
Litton Bionetics Study. Litton Bionetics
studied the chronic effects of sodium saccharin in
Charles River CD male and female rats (12). Groups
of 20 rats of each sex ingested 1% or 5% sodium
saccharin in the diet for periods up to 2 years.
Groups of20 rats ofeach sex did not ingest saccha-
rin. Complete necropsies were carried out. There
were two duplicate studies, which were referred to
as Saccharin I and Saccharin II.
The data from these studies was analyzed at the
NCI and the following conclusions were drawn.
"The only significant differences noted were in
the Saccharin II experiment. Here in the female
rats, the saccharin-fed rats (both doses) had a sig-
nificantly higher proportion of tumorous rats ...
with p = 0.02." (13)
Table 33. Number of male rats ingesting saccharin with tumors
other than pituitary in both studies.
No. of rats
Dose, % Group I Group 2 Total
0 4/16(25%)
1 8/13(62%) 9/15(60%o) 17/28(61%)
5 5/12(42%) 4/14(29%o) 9/26(34%)
(p = 0.02454)
In summary, female rats ingesting saccharin de-
veloped an increase in tumors at all sites when
compared with the controls.
National Institute of Hygienic Sciences (To-
kyo). Sodium saccharin (Taiyo Chemistry Indus-
try) was given to Sprague-Dawley male rats in the
diet for 28 months (37). Groups of 54 rats ingested
sodium saccharin on the following schedule: 2% day
0 to 20, 3% day 21 to 60, 4% day 61 to 150, and 5%
after 150 days. Ten of 16 rats in each group were
killed after 12 months. Many details are not in-
cluded in a brief report.
Eight of 41 control rats were dead by 18 months,
17 of 41 by 24 months, and 27 of 30 by 28 months.
Five of 42 saccharin-treated rats were dead by 18
months, 16 of 42 by 24 months, and 25 of 31 by 28
months.
Tumors were found mainly in the skin of both
treated and untreated rats, as well as the lung in
treated rats. Six of42 rats (14%) ingesting saccharin
and 3 of 41 control rats (7%) had skin tumors; 0%
control rats and 5% of rats ingesting saccharin had
lung tumors. No distinction was made between be-
nign and malignant tumors.
In summary, saccharin-treated male rats had two
times as many tumors as control rats. The tumors
were located mainly in the skin and lung.
Lessel Study. Boots-Wistar rats, 20 per group,
ingested 0%o, 0.005%, 0.05%, 0.5%, or 5% saccharin
in the diet for 2 years (5, 6).
There were increases in benign and malignant
tumors in male rats ingesting 0.05% (46%) or 0.5%
(31%) saccharin for 18 months or longer compared
to 16% in the controls. The incidence of tumors in
control female rats was high. Lymphomas were
present in one control, one rat ingesting 0.005%.
and two rats ingesting 0.5 saccharin. A few rats had
lesions in the urinary bladder.
In this study, there were slight increases in the
incidence of benign and malignant tumors in male
rats ingesting saccharin.
Study ofMunroe et al. Munroe et al. studied
the carcinogenicity ofcommercial saccharin in male
and female Charles River weanling rats weighing
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given 0, 90, 270, 810, or 2430 mg/kg-day sodium
saccharin in a synthetic diet for 26 months (15).
Some rats developed leukemia and lymphoma.
There were also unusual or rare tumors observed
in treated rats but not in the control rats. These
tumors were one hepatocellular carcinoma of the
liver in a male given 270 mg/kg, two cholangiocar-
cinomas ofthe liver in females given 2430 mg/kg, an
adenocarcinoma of the prostate in a male given 270
mg/kg, one malignant mixed mesenchymal tumor of
the uterus in a female given 2430 mg/kg, and two
endometrial adenocarcinomas of the uterus in
females given 810 mg/kg and 2430 mg/kg.
Canadian Health Protection Branch Study
(1977). Male and female Charles River Sprague-
Dawley rats of the Fo generation, 50 per group and
30 days of age, ingested sodium saccharin, 2500
mg/kg-day in a standard laboratory diet for 142
weeks (23). Saccharin was produced by the
Maumee-method and contained less than 0.2 ppm
toluenesulfonamide. Male and female rats were
mated after ingesting saccharin for approximately
90 days. Similar groups ofrats which were exposed
to saccharin in utero and during lactation as a result
of maternal ingestion of saccharin (F1 generation)
and later in the diet received saccharin for 127
weeks. Other rats that did not ingest saccharin
served as controls.
Lymphoma/leukemia, pheochromocytoma of the
adrenal, and biliary cystadenomas ofthe liver were
slightly increased in saccharin-treated F, generation
female rats (Table 34). Two saccharin-treated
female rats of the Fo generation had squamous cell
carcinoma of the renal pelvis.
There was a squamous cell carcinoma ofthe renal
pelvis in one saccharin-treated male rat of the Fo
generation; a papilloma of the urethra in one male
rat given saccharin and a squamous cell carcinoma
ofthe urethra in one male rat given saccharin, both
in the F1 generation.
Table 34. Benign and maligant tumors in female rats
of the F, generation.
Sacchazin-
Tumor Control treated
Benign
Myxoma, heart 0 1
Adenomatous polyp, stomach 0 1
Biliary cystadenoma, liver 1/50 (2%o) 5/50 (10%)
Cortical adenoma, adrenal 2 4
Pheochromocytoma, adrenal 3/50 (16%) 7/50 (14%)
Intraductal papilloma, kidney 0 1
Meningioma, meninges 0 2
Malignant
Lymphoma/leukemia 7/50 (14%) 12/50 (24%o)
Cortical adenocarcinoma, adrenal 0 1
Leiomyosarcoma, small intestine 0 1
There was extensive pelvic epithelial hyperplasia
in the kidney of 11 of49 control and 24 of48 saccha-
rin-treated Fo generation male rats and 10 of49 con-
trol and 32 of49 male rats given saccharin in the F1
generation. Extensive intraepithelial calcification of
the kidney was seen in 3 control and 22 treated male
rats ofthe F,, generation and 4 control and 19 treated
male rats of the F, generation. Seven of 50 control
and 32 of 50 saccharin-treated F1 generation female
rats had extensive pelvic epithelial hyperplasia.
Mouse Studies
Bio-Research Consultants. Two comparable
studies with the same experimental design were car-
ried out. Saccharin was obtained from two sources
(Merck or Monsanto). Random-bred albino male
and female mice (derived from HaM/ICR mice), 25
in each group, ingested 0Wo, 1%, or 5% sodium sac-
charin in the diet for 104 weeks or longer (14). The
mice were 8 weeks old at the start of the study.
Animals dying during the first 6 months were not
autopsied. Thereafter, complete gross autopsies
were done unless mice were too autolyzed for his-
tological examination. Histopathological examina-
tion was done on "'grossly pathological organs ofall
animals and on all vital organs in at least 12 animals
in each group."
There was an increased incidence oftumors at all
sites in the males ingesting 1% (p = 0.001581) and
5% (p = 0.005228) sodium saccharin in each study
(Table 35). In addition, there were increased inci-
dences of tumors of the lung in the male mice in-
gesting 1% sodium saccharin, and tumors of the
vascular system in treated male mice.
In summary, there was an increase in tumors in
all organs in male mice ingesting saccharin. Saccha-
rin was also carcinogenic for the pulmonary and
vascular systems in male mice.
National Institute of Hygienic Sciences (To-
kyo). Male and female dde strain inbred mice, 50
in each group, ingested sodium saccharin (Taiyo
Chemical Industry) in the diet for 21 months (32).
The doses administered were 0%, 0.2%, 1%, or 5%.
Many details are not included in the brief report.
Table 35. Tumors in male mice ingesting saccharin in both studies.
No. of mice
Dose, % Group I Group 2 Total
0 4/19(21%)
1 10/14(71%) 10/15(67%) 20/29(69%7o)
(p = 0.001581)
5 9/15(60%) 12/19(63%) 21/34(62%)
(p = 0.005228)
41/63(65.1%)
(p = 0.000912)
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12 or 18 months.
There were no data concerning the total number
of mice with tumors. Only total numbers of tumors
were given. Total numbers of tumors were in-
creased in female mice ingesting all three doses of
sodium saccharin for 21 months. There were 0
tumors in 14 female control mice, 9 tumors in 18
female mice ingesting 0.2%, 12 tumors in 11 mice
ingesting 1%, and 13 tumors in 12 mice ingesting
5%.
The data are not clear as to the number of mice
with tumors and total number of all tumors. An
analysis ofthe incidence of mice with tumors in any
organ cannot be carried out. There was, however, a
significant increase in the number of mice ingesting
saccharin with ovarian tumors.
Study ofRoe et al. The study of Roe et al. was
concerned with the effect of saccharin on
benzopyrene-induced (BP) tumors of the fore-
stomach in female albino mice (36). Control mice
received a single gastric instillation of the BP vehi-
cle, PEG, followed by the ingesting of 5% saccha-
rin. Mice were killed 18 months after the start ofthe
experiment.
"Because of a misunderstanding, mice were not
allocated randomly to the eight treatment groups.
The oldest, and therefore heaviest, mice were in-
cluded mainly in the control groups (groups 1 and 2)
while the lightest and youngest mice were allocated
to test groups 3-8."
Postmortem examinations were carried out on
mice killed or found dead. All major organs, in-
cluding the urinary bladder, but excluding the
cranium, were examined grossly. All tumors, or le-
sions suspected of being tumors were studied his-
tologically. Urinary bladders were not sectioned
histologically.
Tumors were not increased in mice ingesting sac-
charin; however, results must be reexamined be-
cause of the different ages for control and
saccharin-treated mice. Subcutaneous sarcomas,
sarcomas of the uterus, and undifferentiated lung
tumors were observed in older control mice and not
in younger mice.
Study ofKroes et al. Kroes et al. gave Swiss-
SPF male and female mice, 50 of each sex per
group, 0Wo, 0.2%, or 0.5% saccharin (Bayer Farma,
N. V., Amsterdam) in the diet for 21 months (30).
Large numbers of mice died before 18 months.
The results stated that the incidence of
amyloidosis of the kidney was increased in females
receiving 0.5% saccharin. Leukemia and "pro-
liferative alterations in the lungs" were frequently
observed. The data concerning controls and
saccharin-treated mice was not given.
Swiss-SPF mice are not suitable for long-term
carcinogenicity studies. Amyloidosis of the kid-
neys, as well as other diseases, interfere with their
health and shorten their life span.
No conclusions concerning the carcinogenicity of
saccharin, other than the urinary bladder, can be
made from this study.
Other Studies
Study of Althoff et al. Saccharin (Sigma
Chemical Co., St. Louis, Missouri) was adminis-
tered to male and female Syrian golden hamsters
(38). Groups of 30 males and 30 females received
0%, 0. 156%, 0.312%, 0.625%, or 1.25% saccharin in
the drinking water. Average survival was from 50 to
60 weeks.
The results include only a list ofthe tumors found
in the hamsters in the study. There were three
tumors in treated females; whereas no tumors were
seen in the control females. In addition, "generalized
amyloidosis and vascular calcinosis, common in
animals over 40 weeks of age, were found in both
untreated and treated hamsters. The incidence in all
treated animals was higher than in contemporary
controls....' No mention is made ofchronic renal
disease, although there were adenomas of the
parathyroid glands.
No conclusions concerning the carcinogenicity of
saccharin can be drawn from this subchronic study.
These hamsters are not suitable for long-term car-
cinogenicity studies. Amyloidosis, vascular cal-
cinosis, and other diseases interfere with their
health and shorten their life span. Furthermore, the
study was primarly concerned with low dose levels.
Saccharin was administered in the water.
Study of McChesney et al. Rhesus monkeys,
male and female were given soluble saccharin, 0,
20, 100, or 500 mg/kg-day 6 days a week for 79
months (39, 40). There were two or three monkeys
in each group. There were two deaths in the control
group and one in each of the experimental groups,
which were not attributed to the administration of
saccharin.
No conclusions concerning carcinogenicity of
saccharin can be made from this study. The data is
given in abstract form. Six and one-half years is not
considered as sufficient for a carcinogenicity study
in monkeys.
Summary
The findings are summarized in Table 36.
Early studies suggested that tumors at all sites,
particularly malignant tumors, might be increased in
rats ingesting saccharin in the diet. Later studies
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Number (%) with tumors
Study Year Dose, % Type of tumor Animal Controls Treated p
Warf 1973 5 Benign Rat (male) 2/16(13%) 3/16 (19%o)
Malignant 1/16( 6%) 11/16 (69%) (0.000318)
Benign and 3/16(19%) 14/16 (87%) (0.000122)
malignant
FDA 1973 5 Malignant Rat (male 3/56(5.4%) 11/53 (21%) (0.016050)
7.5 and female) 17/58 (29.3%) (0.000647)
0.01-7.5 49/290(17%) (0.015698)
Bio-Research 1973 1 Benign and Mouse (male) 4/19(21%) 20/29 (69%) (0.001581)
Consultants 5 malignant 21/34 (62%) (0.005228)
1 + 5 41/63 (65%) (0.000912)
disclosed that, indeed, benign and malignant
tumors, or malignant tumors alone, were increased
in male and female rats and in male mice ingesting
saccharin. Male rats were more susceptible to the
development of malignant tumors than were female
rats, more so at the highest doses. Unusual malig-
nant tumors were sometimes found in saccharin-
treated rats and not in the controls.
There also were increased incidences oftumors at
specific sites, i.e., specific organ systems. Tumors
were seen chiefly in the urinary, reproductive, and
hematopoietic systems, and also in the lungs, vas-
cular system, and squamous epithelium.
Comments
The arguments for ignoring the results of the
tumors developing in the urinary bladder were: (1)
small numbers of rats with tumors; (2) tumors were
caused by stones in the urinary bladder; (3) tumors
were caused by parasites in the urinary bladder; (4)
tumors were not dose-related and occurred only at
the highest doses; (5) tumors were caused by the
impurity, o-toluenesulfonamide, and not by saccha-
rin; (6) tumors developing in the bladder implanta-
tion study and certain other studies were irrelevant;
(7) tumors ofthe urinary bladder were not preceded
by the development of preneoplastic lesions and
were not very malignant; (8) studies were not well
planned; (9) tumors did not develop in organs other
than the urinary bladder; and (10) studies have
shown saccharin to be safe for humans.
Small Numbers of Rats with Tumors
Studies with small numbers of rats ingesting sac-
charin with tumors of the urinary bladder were
readily dismissed, even though some stocks of un-
treated rats did not develop such tumors. The re-
sults of such studies were interpreted as proving
that saccharin was not carcinogenic for rats. The
results actually indicated that saccharin would
probably be carcinogenic if large enough numbers of
animals had been used in the studies.
Rats ingesting saccharin also developed signifi-
cant numbers oftumors or polyps ofthe renal pelvic
mucosa, a further indication that saccharin would
be carcinogenic for the similar mucosa of the uri-
nary bladder.
Tumors Were Caused by Stones in the
Urinary Bladder
There was never any evidence that the tumors
were caused by stones in the urinary bladder. There
was even less evidence in one study that "in the
case ofthe third rat with bladder lesions, the reason
is uncertain, for no stones were found though they
might have been present and later voided" (6). If
one carefully examines the data in the rats that did
have both stones and tumors, the lesions in the uri-
nary bladder preceded the occurrence of stones,
and in no instance did the stones precede the de-
velopment oftumors ofthe urinary bladder (17, 20).
The relationship was best observed in th'e study in
which not one rat with a tumor of the urinary blad-
der had stones (20). Conversely, not one lesion or
tumor of the urinary bladder was found in the large
number of rats with stones in the bladder.
Tumors Were Caused by Parasites in the
Urinary Bladder
Those searching for an explanation for the tumors
in the urinary bladder in rats that did not have
stones or that presumably "voided" the stones after
a tumor developed came up with parasites. The
tumors were not induced by saccharin, but they
were caused by parasites in the urinary bladder.
They cited a study "'A nematode, . . ., the adult
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found to increase significantly the number of blad-
der tumors developing in rats fed . . ." (25). The
data ofthat study, tumors in 5 of 156 rats with para-
sites, did not demonstrate that parasites were re-
sponsible for the development of tumors of the
bladder. The author did state that "because none of
ourrats developed calculi, it seems unlikely that the
stone formation mechanism holds true in this case."
Parasites also were not observed in the study in
which the development of tumors of the urinary
bladder was not associated with stones in the uri-
nary bladder (20).
Tumors Were Not Dose-Related and
Occurred Only at the Highest Doses
Chronic renal disease results from the adminis-
tration oflow doses of saccharin and tumors of the
renal pelvis and urinary bladder develop with the
higher doses. Tumors or polyps of the renal pelvis
in rats ingesting saccharin were clearly dose related;
however, tumors of the urinary bladder were ob-
served in rats given the highest dose levels. One
female rat ingesting 0.05% saccharin developed an
undifferentiated malignancy of the urinary bladder
(19). At lower doses saccharin may not reach the
urinary bladder and could not be expected to pro-
duce tumors. Tumors developed in organs other
than the urinary bladder in animals given lower
doses. Chronic renal disease in rats given the lower,
as well as the higher doses, may have shortened the
life span and/or interfered with the development of
tumors. It is not necessary for tumors to develop at
all dose levels in order for a chemical to be car-
cinogenic.
Tumors Were Caused by the Impurity,
o-Toluenesulfonamide, But Not by
Saccharin
It was highly unlikely that the impurity, o-
toluenesulfonamide, was inducing the tumors ofthe
urinary bladder. The doses, compared to those of
saccharin, were relatively small. The fact that
human beings were consuming the same chemicals
makes this criticism irrelevant. More recent studies
used saccharin that had fewer impurities or none at
all (14, 19, 24, 31), and animals developed tumors
just as they did in earlier studies. In a recent study,
o-toluenesulfonamide was not carcinogenic for the
urinary bladder of rats (24).
It is worth noting that human beings ingesting
saccharin also are in contact with other chemicals,
and that in the past saccharin and cyclamate were
ingested together. (Some studies in which saccharin
was given with cyclamate were regarded as irrele-
vant; however, for these reasons such studies
should have been considered in the evaluation of
saccharin.) It is particularly well put in one study:
"Man, however, is exposed to a complex environ-
ment, in which he may simultaneously encounter
potentially carcinogenic chemicals in the food he
eats, in the air he breathes, in the tobacco smoke he
inhales, and in the factory where he works" (18).
Tumors Developing in the Bladder
Implantation Study and Certain Other
Studies Were Irrelevant
The carcinogenicity of saccharin was studied by
implanting pellets of cholesterol and saccharin into
the urinary bladder of mice. This route of adminis-
tration, i.e., direct application to the urinary blad-
der, was considered as not appropriate, even
though saccharin is concentrated in the urinary
bladder of animals (41). Shimkin, at an NCI Sub-
committee Meeting, recently pointed out that the
severity ofthe lesions, as well as the route, needed
to be taken into consideration (42). An FDA official
also stated that all studies, including bladder im-
plantation studies, should be considered in the
evaluation of a chemical for carcinogenicity (43).
Tumors developed in the urinary bladder of mice
with saccharin and cholesterol pellets (26, 27).
These tumors in the urinary bladder of mice with
saccharin implants were often undifferentiated and
highly anaplastic. The tumors also were more
malignant than those induced by cyclamate and
were comparable to those induced in mice, rats, and
dogs by other carcinogens. Saccharin also was
cocarcinogenic for the urinary bladder in rats and
was a tumor initiator when applied to the skin (17, 18,
35).
Tumors of the Urinary Bladder Were Not
Preceded by the Development of
Preneoplastic Lesions and Were Not Very
Malignant
The tumors of the urinary bladder in rats given
saccharin in at least two studies were preceded by
the development of preneoplastic lesions, i.e.,
hyperplasia (17, 20), and are similar to tumors de-
veloping in the urinary bladder of rats given other
chemicals. Hyperplasia, observed as early as 4
months, was mild, moderate, or severe in degree.
The hyperplasia later became polypoid and pro-
gressed to carcinomas.
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based upon morphologic criteria by the NAS
Pathology Subcommittee, as well as others (16, 22).
The carcinomas sometimes were invasive. Tumors
of the urinary bladder in mice were often undiffer-
entiated and highly anaplastic, invasive, and occa-
sionally metastatic (26). They were more malignant
than those induced by cyclamate and were compar-
able to those induced in mice, rats, and dogs by
other carcinogens.
Tumors need not have metastasized in order to be
malignant (44). Diagnoses of carcinomas can be
based on morphologic criteria. Animals often do not
live very long after the development ofcarcinomas.
Therefore, it is not unusual to find carcinomas in
rats that have not metastasized (45). In most animal
studies, a careful search was not made for meta-
stases. In order to be certain that metastases have not
occurred, it would be necessary to do serial sections,
not only oflymph nodes, but ofother organs as well.
Studies Were Not Well Planned
The plan of some studies was criticized by the
NAS Committees (46, 47). In recent studies, these
criticisms were taken into consideration. Treated
rats were exposed to saccharin from inception (19,
24, 31). Control rats were given sodium carbonate
(31), the saccharin contained fewer or no impurities
(14, 24), and one study was carried out for 28
months (31).
Tumors Did Not Develop in Organs Other
than the Urinary Bladder
National Academy of Sciences Committees, as
well as some investigators, felt that saccharin did
not induce tumors in organs other than the urinary
bladder; however, benign and malignant tumors, or
malignant tumors alone were increased in male and
female rats ingesting saccharin. Male rats were
somewhat more susceptible to the development of
malignant tumors than were female rats, more so at
the highest doses. Unusual malignant tumors were
sometimes found in saccharin-treated rats and not
in the controls. There were also increased inci-
dences of tumors at specific sites in mice and rats
ingesting saccharin. Tumors were found chiefly in
the reproductive and hematopoietic systems, and in
the lungs, vascular system, and squamous
epithelium. Therefore, organs other than urinary
bladder and renal pelvis in rats and mice ingesting
saccharin had benign and malignant tumors.
Studies Have Shown Saccharin to be Safe for
Humans
Saccharin is rapidly absorbed, distributed
throughout the body, and excreted unchanged, ex-
cept for 1% or less as metabolites, in the urine of
animals (48-50). Saccharin is concentrated in the
kidney and urinary bladder (41, 51). Saccharin
crosses the placenta and is found in all tissues ofthe
fetus ofsubhuman primates (48). Another nonnutri-
tive sweetener, cyclamate, is present in largest
amounts in the liver, spleen, and kidney ofthe fetus
following placental transmission in human and
macaque pregnancies (52).
Although reports ofmany studies were available,
conclusive evidence was lacking as to whether or
not saccharin is mutagenic. A study using more sen-
sitive methodology and tester strains found that
saccharin preparations commonly distributed as ar-
tificial sweetners were mutagenic in bacterial tests
(53). Highly purified saccharin was not mutagenic in
the direct assay, but the urines of mice given this
material were mutagenic.
Results from animal studies can be used to pre-
dict the impact of the test substance on human
health (54).
"'Qualitatively, it has been shown that the forma-
tion and occurrence of tumors in man and other
mammals-such as hamsters, mice and rats-is
quite similar. In tests undertaken to date, it had
been demonstrated, with one possible exception
(arsenic), that every chemical which has been found
to be carcinogenic in man is also carcinogenic in one
or more mammalian test animals. Furthermore, the
majority of chemical carcinogens which have
undergone sufficient testing have been shown not to
be species specific. That is, testing has shown that if
these compounds will produce tumors in one
species, it will very likely produce tumors in more
than one, thus adding weight to any finding of car-
cinogenicity in tests using any mammalian species.
Sufficient documentation is available on qualitative
extrapolation ofanimal data that one must conclude
that a finding of carcinogenicity in one mammalian
species should be deemed to have relevance for
other mammalian species-including man."
"Quantitatively, one must assess the relationship
between the dosage required to produce tumors in
test animals and that required in man. This assess-
ment, difficult as it is, is complicated by the fact that
man is much more variable in his physical charac-
teristics than are most other species of mammals.
One can state, however, that it is quantitatively im-
possible to establish any safe level ofdistribution of
a carcinogen in the environment. A safe level may
exist for a particular human being, but because
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impossible to establish such a level for a commu-
nity. Furthermore, review of the literature on car-
cinogenicity tests suggests that no such null effect
threshold or safe level has been determined in test
animals-much less for man-for virtually any known
carcinogen."
The three epidemiological studies which are re-
ported as showing no increase in cancer of the uri-
nary bladder in humans, have been critically re-
viewed elsewhere (55-58). A recent study in Canada
concluded that there is an estimated 60% increase in
the risk of cancer of the urinary bladder associated
with the use of artificial sweeteners (primarily sac-
charin) in men (59, 60). The risk ratios increased
with both frequency and duration of saccharin
usage, with the trend being statistically significant
in both cases. For all men using saccharin 7%, and
for diabetic men 33%, ofcancer ofthe urinary blad-
der might be ascribed to the use of artificial
sweeteners.
Summary of the Carcinogenicity
Studies in Animals
The findings ofthe carcinogenicity studies in rats,
mice, and other animals are summarized in Tables
37, 38, and 39.
Table 37. Summary of carcinogenicity studies in rats.
Generation, Concentration,
Authors Stock age, sex % Duration Carcinogenicity Comments
FDA Osborne-Mendel F0(3 weeks) 0,0.01,0.1 2 yr Lymphosarcoma Urinarybladdernot examined
(1948-1949) male, female 0.5,1,5 Renal pelvis Chronic renal disease
Hyperplasia bone marrow
Lessel Boots-Wistar Fo 0,0.005,0.05, 2 yr Urinary bladderlesions Some bladder stones
male, female 5
Litton Charles River Fo 0, 1,5 2 yr All sites No bladderstones
Bionetics, Inc. CD male, female Urinary bladder tumors Chronic renal disease
Bio-Research Charles River Fo 0, 1, 5 2 yr Urinary bladder tumors Hyperplasia renal pelvis
Consultants Sprague-Dawley male, female No bladderstones
Some parasites
Munroe, et al. Charles River Fo weanling 0,0.15,0.5,1.5,5 26 mo Urinary bladdercarcinoma No bladderstones with tumors
male, female No parasites
WarfInstitute Sprague-Dawley F, 0,0.05,0.5,5 100 wk Urinary bladdercarcinoma No bladder stones, Parasites and
male, female All sites renal disease not mentioned
Uterus and ovary
FDA (1973) Charles River F1 0,0.01,0.1,1, 14,18 mo Urinary bladdercarcinoma Nobladderstoneswith tumors
Sprague-Dawley male, female 5, 7.5 Renal pelvis Noparasites
Mammary gland Hyperplasiaofurinary bladder
All sites Chronic renal disease
Fo 4,6,12mo Hyperplasiaofurinary bladder
male, female
Arnold, etal. Charles River Fo 0,5 148 wk Urinary bladder tumors Noparasites
Sprague-Dawley male, female No relationship ofbladder stones
F1 127 wk Urinary bladdercarcinoma totumors
male, female Incidence higher inF, than Fo
Metastases from urinary bladder
carcinoma to lymph node
Schmahl Fo 0,0.2,0.5 Lifetime Lymphomaand leukemia High death ratsfromrespiratory
male,female infections
NIHS, Tokyo Sprague-Dawley Fo 5 12,28 mo Lung tumors Dataincomplete
male Skin tumors
Hicks etal. Wistar Fo, 150g, 4,8 95 wk Urinary bladdertumors Controls forcocarcinogenesis
male, female studies.
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Authors Stock Age, sex Concentrations, % Duration Carcinogenicity Comments
Bio-Research Albino 8 wk 0, 1, 5 >104 wk All sites
Consultants (HaM/ICR) male, female Lung
Vascular
Uterus
NIHS, Tokyo dde Male,female 0,0.2, 1,5 12,18,21 mo Ovary Dataincomplete
Roe et al. Albino Female 5 18 mo Inconclusive Controls given single dose
ofvehicle PEG for
benzopyrene study
Control and test mice were
different ages at start
ofexperiment
Kroes et al. Swiss-SPF Male, female 0,0.2, 0.5 Long-term Amyloidosis Swiss-Webster mice not suitable
70-90 days kidney for such a study
Urinary
bladder
tumors
Table 39. Summary of other carcinogenicity studies.
Stock
Authors species Age, sex Concentrations Duration Carcinogenicity Comments
Hicks et al. Wistar rats Male, 4, 8% oral 95 wk Cocarcinogenic for urinary
female bladder carcinomas with
MNV
Bryan et al. Swiss mice Female Cholesterol + saccharin 13 mo Urinary bladder carcinomas
60-90 days pellets in urinary
bladder (5-6 mg saccharin)
Allen et al. Mouse stock Cholesterol + saccharin Urinary bladder tumors
pellets in urinary bladder
(approximately 3 mg
saccharin)
Althoff et al. Syrian Male, 0, 0.156, 0.312, 0.625, 62 wk Inconclusive Short duration
golden female 1,25%
hamsters
Golberg Rhesus Male, 0, 20, 100, 500 mg/kg-day 79 mo Inconclusive Data incomplete
Short duration female
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